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INTRODUCTION
Lung cancer is the leading cause of death from cancer world wide. A total of 
9400 patients died in 2006 of lung cancer in The Netherlands, which is 7 % of all 
deaths. Since the 1980’s mortality rates from lung cancer have been progressively 
declining in men, and slowly rising among women (CBS 2010). This is believed to 
be caused by changing smoking habits in both sexes. Survival rates in lung cancer 
patients are directly related to the presence of metastases, since curative options 
are mainly available in N0-1 and M0 disease. 
Prognosis according to the N category. A: overall survival by cN category (any cT, cM0) 
using the IASLC classification. B: overall survival by pN category (any pT, pM0) using the 
IASLC classification.  MST = median survival time (months); 5-year = 5-year overall. 
Reprinted with permission from Detterbeck FC et al. Chest 2009;136:260-271.
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Prognosis according to the M category. A: overall survival by T4 and M category by clinical 
stage. B: overall survival by T4 and M category using the best stage (pathologic stage if 
available, otherwise clinical stage). Ipsi = ipsilateral; NS = not significant. MST = median 
survival time (months); 5-year = 5-year overall. 
Reprinted with permission from Detterbeck FC et al. Chest 2009;136:260-271.
Surgery remains the ultimate modality to accomplish this, although stereotactic 
radiotherapy is currently under investigation as primary therapy in N0 disease. 
Nevertheless, nodal staging is of vital importance in every lung cancer patient, 
both for assessment of prognosis and optimal choice of therapy . 
Since 1966 the first Tumor, Node and Metastasis (TNM) classification has been 
introduced, which led to the new and revised 7th edition in 2010 (1). The TNM 
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classification has been introduced to unify staging and to prevent discrepancies 
originating from two separate lymph node staging systems, the Japanese (Naruke) 
and the European (Mountain-Dresler) (2,3). 
Lymph node staging is a crucial element in the work-up of lung cancer patients. 
Radiological staging has changed considerably with the advent of whole-body FDG-
PET scan (4), in addition to, or combined with,  CT-scanning (5). These techniques 
for the mediastinum however, are still limited in their sensitivity and specificity. 
FDG-PET sensitivity and specificity are 75-85% and 75-90% respectively, and in 
case of CT-scanning sensitivity rates are 50-75%. In a combined FDG-PET-CT setup 
sensitivity for mediastinal lymph nodes is higher in several reports, but has not 
replaced invasive staging of the mediastinum (20).
In 1949 Schiepatti was the first to perform Transbronchial Needle Aspiration 
(TBNA) in lung cancer patients by means of rigid bronchoscopy and was adapted 
by Wang and Terry in 1983 for use in the flexible bronchoscope (6,7). Since then, 
TBNA has proven to be an excellent procedure to obtain histological and cytological 
samples of enlarged mediastinal lymph nodes. This can be explained by the ease 
of the procedure, low cost, low complication rate, and relatively high diagnostic 
yield, even in primary care centers (8). This is in contrast to the endobronchial and 
esophageal ultrasound techniques both of which require expensive equipment 
and intensive training. TBNA is indicated in patients with enlarged mediastinal 
lymph nodes abutting the trachea, subcarinal region, and main bronchi. Also, hilar 
nodes (N1), endobronchial lesions and peripheral nodules can often be reached. 
Adequate sampling of mediastinal nodes can also provide other diagnoses, such 
as sarcoidosis, malignant lymphoma and tuberculosis (9-11).
OUTLINE OF THE THESIS
The central objective of this thesis is the evaluation of TBNA in the work-up of 
lung cancer patients in a non-universitary teaching hospital. This includes the 
assessment of the diagnostic yield of different TBNA needles, and the comparison 
of cytological and histological diagnosis. Besides, the learning curve of TBNA 
has been evaluated. Finally, the cost-effectivity of TBNA, compared to EBUS and 
mediastinoscopy, has been assessed.
The evaluation of the role of TBNA in the work-up of lung cancer is very relevant 
today; TBNA has never been part of the daily routine in many centres  around 
the western world, as the procedure was considered to be difficult. Many 
pulmonologists did not learn to perform TBNA during their training. 
Today, evaluation of the mediastinal  lymph nodes is increasingly performed under 
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direct ultrasound guidance. The endoscopic approach can be by the esophagus 
(esophageal ultrasound or EUS), or by the bronchial tree (endobronchial 
ultrasound or EBUS).  
 These techniques have gained much popularity under pulmonologists in a short 
period. Although the diagnostic yield may be higher because the lymph nodes 
can be visualised, and can be punctured under real time ultrasound guidance, 
there are some disadvantages: a separate endoscopy (oesophagoscopy or 
bronchoscopy) is necessary to perform respectively EUS or EBUS. 
EBUS, in contrast to conventional TBNA, can not be performed together with the 
original bronchoscopy, because the EBUS bronchoscope is not fit for inspection of 
the bronchial tree. 
An important disadvantage of EUS is the limited reach of lymph nodes; the 
important nodes on the right side, 2R and 4R, are often out of reach, which makes 
a complete staging of the mediastinal lymph nodes impossible.
In this thesis, we will evaluate  the  place of conventional TBNA  in the era of 
upcoming ultrasound guided endoscopic techniques.
Chapter 2 will provide a practical guideline on how to perform TBNA and describe 
the different techniques used to obtain lymph node tissue. This chapter is 
illustrated with graphics designed for this purpose.
This thesis describes in Chapter 3 the yield of TBNA in lung cancer patients. 
Excellent results have been published by experts. However, little information 
is available about the diagnostic yield of TBNA with the histology needle in a 
non-expert center. This study evaluates the safety and effectiveness of  TBNA in 
obtaining cytology and histology in mediastinal lymph nodes, in a non-university 
setting. This study has been performed in the pre-PET scan era while positron-
emission tomography (PET) has show to improve TBNA results (12-13).
In Chapter 4, the yield of eXcelon®, a new transbronchial aspiration needle, is 
evaluated. This prospective study was undertaken to assess the utility of this 
new needle in patients with enlarged mediastinal lymph nodes. Although this 
new needle originally has been designed for cytology aspiration, the diameter 
of the needle may also be suitable for histology samples. We previously used the 
Mill-Rose Wang 319® histology needles which were specially designed for taking 
histology samples (8). Obtaining histology is of great importance, especially in 
granulomatous diseases such as sarcoidosis, tuberculosis, or other malignancies 
such as malignant lymphoma (14-17). 
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In Chapter 5 we describe the learning curve of TBNA in otherwise experienced 
bronchoscopists. It has been only rarely subject to study if experienced 
bronchoscopists will be able to perform TBNA with satisfactory results in a short 
time (18, 19). The individual results of five bronchoscopists with 1- to 18-year 
experience in bronchoscopy before performing TBNA have been analysed.
 
In order to learn more about the reliability of the cytological vs. histological 
yield in TBNA, chapter 6 was designed to discuss the additional information of 
histology specimens compared to cytology obtained from the same lymph node. 
Two pathologists randomly revised TBNA of 50 patients in which histological and 
cytological material was obtained. Results were compared afterwards. 
In Chapter 7, the use of  TBNA during the first bronchoscopy in the work-up of 
patients suspected of lung carcinoma  to demonstrate N2 or N3 disease after 
previous PET/CT scan is assessed. If stage III lung cancer already is demonstrated 
during the first bronchoscopy, savings can be made on additional and often 
expensive analysis of mediastinal nodes (EBUS, mediastinoscopy).
13
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INTRODUCTION
Transbronchial Needle Aspiration is performed during routine bronchoscopy 
performed on patients with mediastinal lymph node enlargement. In this chapter 
the different techniques used in TBNA are discussed. In previous studies, several 
techniques have been described with different needles, usually variations on the 
needle developed by Ko-PenWang (1-3). 
Techniques used in this thesis are described on a step-by-step basis with a focus 
on the experience in the use of the new eXcelon® needle developed by Boston 
Scientific. Previous studies have described several ways of catheter manipulation 
such as the “jabbing method”, “hub against the wall”, “piggyback method” and 
the “cough technique” (1-3). These techniques are developed in the early 90’s of 
the previous century. They focus on catheter manipulation unrelated to the target 
site. The experience gained in the build-up of this thesis warrants a different 
approach, focussed on lymph node localisation and the angle of the bronchoscope 
depending on lymph node station. This is an essential different way of choosing 
puncture technique. Other factors such as bleeding tendency, prominence and 
consistency of tracheal cartilage, uncooperative patients and number of nurses 
present play a vital role in the choice of puncture technique. 
In this chapter different techniques will be described in relation nodal station 
and angle in which nodal penetration is warranted: straight penetration 
(bronchoscope, catheter and needle in a straight line) and angled penetration of 
the bronchial wall, in which case the tip of the bronchoscope is bent or in some 
cases a straight bronchoscope and angled TBNA guide wire is used.
1) Choosing target sites
Before bronchoscopy commences it is important to take good notice of the 
localisation of the mediastinal lymph nodes. CT imaging, and preferably also FDG-
PET, has to be studied intensively and target lymph nodes should be chosen on 
radiological grounds. Not only target size, but –more importantly – treatment 
relevant localisation is important. At least the largest mediastinal node should 
be sampled because diagnostic yield is directly related to lymph node size. 
Secondly, treatment relevant lymph node localisation is an important factor. A 
small contralateral lymph node can be essentially more important than ipsilateral 
larger lymph nodes. The same argument is valid when non-mediastinal nodes 
(e.g. nodal station 11 and 12) or the primary tumor are considered for TBNA.
Selecting a puncture technique is of later concern when local status has been 
evaluated during inspection bronchoscopy. For illustration purposes a nodal map 
is shown below in Figure 1 (TNM classification, 7th edition). 
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Figure 1. 
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2) Preparation
Bronchoscopic procedures are performed on spontaneous breathing 
patients, without endotracheal intubation. Midazolam or Propofol sedation in 
spontaneously breathing patients can be an aid in performing TBNA, but can limit 
the use of the “cough technique” as described below.  TBNA in intubated patients 
is possible, but the number of accessible lymph nodes is limited to nodal stations 
7, 4, 11, and in some cases 12 (revised 7th edition of TNM classification) depending 
on the depth of the endotracheal tube and bronchial diameter. Also, movement 
of the bronchoscope is limited, which may reduce the yield of TBNA in several 
techniques. 
Preferably two bronchoscopy nurses are present in the theatre. Before the 
catheter is advanced into the working channel of the bronchoscope it is vital to 
make sure that the needle is retracted in the metal hub to prevent laceration of 
the working channel of the bronchoscope. In normal bronchocopic procedures, 
inspection of the bronchial system has been performed before TBNA is started. 
The bronchoscopist therefore has a good understanding of the image of the 
main airways and the presence of potential confounding endobronchial factors 
as mucus, pus, blood or endobronchial tumor tissue. Also, vulnerability of the 
endobronchial wall to bleeding is important to notice when inspecting the 
bronchial tree. For instance, in a bronchus with vulnerable mucosa, the “Jabbing” 
or “Piggyback” techniques are not preferred as is explained later. External factors 
such as a non-cooperative patient may make it difficult to perform the “cough 
technique”. TBNA is performed prior to other investigations such as biopsies, 
brush or washings to minimize the chance of false-positive results, although no 
randomized trials have been performed to verify this assumption.
3) Choosing a needle
Today, several types of needles are available for TBNA. They all consist of a basic 
construction as is presented below. Needles are available in different diameters 
as discussed in this thesis. A major development since the last decade is the 
shift from a double (both bevelled), to a single needle system. The first TBNA 
needles as developed by Wang consisted of an inner and outer needle at the 
end of the guide wire. The inner needle was designed to prevent plugging of the 
outer needle with bronchial mucosa. Later, the eXcelon needle was developed by 
Boston Scientific without the inner needle. The diagnostic yield of a 19G single 
needle for both cytology and histology samples is described in the thesis, and 
compared to the diagnostic yield of a double needle in the existing literature. 
To the authors’ knowledge, there are no studies which compared both systems. 
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In this thesis, two needles have been used. One double needle system, the MW 
319 histology needle (Mill-Rose Laboratories, Mentor, Ohio, USA) and the single 
needle eXcelon aspiration needle (Boston Scientific, 19 Gauge). Both concepts are 
graphically presented below. 
22
TBNA Techniques. A manual for daily practisechapter 2
23
TBNA Techniques. A manual for daily practise chapter 2
4) choosing puncture technique
There are 4 basic puncture techniques as presented in diagrams below. They will 
be discussed briefly. The techniques will be illustrated with the following diagram:
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a) Hub Against The Wall Method. 
This is considered to be the safest method and most widely used. This is best 
performed with a second nurse present who fixates the sheath at the proximal 
end of the bronchoscope, making sure the metal hub is half in, and half out of the 
bronchoscope. This prevents bending of the flexible part of the system outside the 
working canal, making the entire system more rigid. In a one nurse setting, using 
this technique the eXcelon needle is preferred. In case of the MW 319 needle, the 
nurse needs two hands extending the needle, making the Hub Against the Wall 
Method less feasible. 
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The distal end of the catheter (the metal hub) is directly pushed against the wall 
between two cartilage rings and subsequently the needle is pushed through the 
bronchial wall. In case of a stiff endobronchial wall or cartilage is hit, the needle 
will come out the metal hub, without penetrating the lymph node. In this case 
one can immediately apply the Jabbing Method (See pictures above). 
b) Jabbing Method. 
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In this method the needle is extracted from the sheath inside the tracheal lumen 
before passing through the mucosa. This can be a primary technique, but can also 
follow a failed attempt of the Hub Against The Wall method. Once the needle 
is extracted and the bronchoscope is fixated, an abrupt, firm jabbing motion 
with the sheath is made towards the bronchial wall in an attempt to enter the 
lymph node. Preferably a second nurse fixates the bronchoscope 1-2 cm from 
the mouth of the patient preventing recoil of the bronchoscope. A danger using 
this technique is the presence of a patient in distress or uncontrolled coughing. 
With the needle extracted and large, uncontrolled  movements of the trachea (i.e. 
coughing) occur, the inner mucosa can be lacerated and cause bleeding, hindering 
further procedures due to impaired vision. Besides, the guidewire has the risk of 
dislocating and bending when the metal hub completely leaves the bronchoscope 
(see pictures below).
Since the needle is extended before positioning the bronchoscope, both the 
eXcelon and MW 319 needle can be used in this technique.
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c) Piggyback Method. 
This is a variant of the Jabbing Method in which not only the catheter is jabbed 
towards the lymph node (with the needle extended from the metal hub), but 
the bronchoscope and the sheath together. One advantage of this method over 
the Jabbing Method is that it can be performed without a second nurse fixating 
the bronchoscope, making this procedure also feasible with the MW 319 system 
compared to the eXcelon needle. Also, there is less chance of the sheath bending 
in de lumen of the trachea, when the metal hub stays partly inside the scope 
maintaining a rigid system. A large disadvantage is the sudden, fast movement of 
the bronchoscope and therefore also the image on the monitor, since the camera 
is moved as well. 
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d) Cough Method. 
This method is intended as an aid to the Hub Against The Wall and Jabbing 
technique. When the metal hub or the needle respectively are positioned against 
the mucosa, the patient is asked to present a firm, single cough and thereby 
lifting the entire bronchial system towards the bronchoscope and thus facilitating 
penetration of the lymph node. This can only be applied in cooperative patients. 
Present experience with this technique proves it to be a very useful aid to 
successful TBNA.
29
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5) Performing TBNA: straight angle penetration
Straight angle penetration can be performed on nodal stations 4, 7, 11 and 
sometimes 12. The classical example is nodal station 7. All four techniques 
mentioned above can be used, although the “Piggyback” method is the 
least favourable option, because –in contrast to the Jabbing method – the 
bronchoscopist has less control and overview, because of camera movement 
during TBNA. The author has a preference for the Hub Against the Wall method 
for several reasons. The main reason is that the needle is only exposed when 
the metal hub is in position for penetration. The Jabbing and Piggyback method 
give risk of (usually small) mucosal bleeding when coughing commences in the 
time interval between extension of the needle and actual penetration. In the Hub 
Against the Wall method, the needle often does not at all present itself in the 
bronchial or tracheal lumen, because it penetrates the mucosa the moment it 
leaves the metal hub. 
The second argument entails the fact that in the Hub Against the Wall method, 
the stiff metal end of the sheath has less chance of dislocating from the tip of 
the bronchoscope, making the entire system less rigid and therefore more 
unpredictable. 
For straight angle penetration, this puncture technique can be performed with 
one nurse present instead of two, although two is recommended. In a one-nurse 
setting, the nurse fixates the sheath at the proximal end of the bronchoscope, with 
the metal hub half way out of the bronchoscope. The bronchoscopist positions 
the entire system at the desired location. Then the needle is extended with one 
hand by the nurse. 
6) performing TBNA: angled penetration
Angled penetration with TBNA is considered any situation in which TBNA is 
performed with the tip of the bronchoscope in any bent position. Sometimes 
angled penetration van be performed with a straight bronchoscope, but angled 
TBNA sheath. This latter option is only feasible in case of a very soft mucosa and 
will not be discussed further.
Angled TBNA is more difficult than straight penetration and can be performed on 
stations 2, 4 and sometimes 10. In case of small angles, the metal hub can still be 
placed half way out of the bronchoscope, but when the tip of the scope is bent 
to extreme angles, the sheath has too little movement capabilities because of 
friction. 
When performing TBNA with an angled bronchoscope, the Jabbing Method can be 
very useful, since the Hub Against the Wall technique might result in dislocation 
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of the metal hub when positioning the system for puncture. Still, a variant of the 
Hub Against the Wall method is feasible in a straight angle setting as depicted 
below.
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Another technique which is available in the angled setting, and which has not 
been described before, can be called the “Locked Needle Technique”. In this case, 
the needle is extended from the sheath and – like the first stage of the piggyback 
method – advanced with bronchoscope and sheeth in fixed position forward until 
the needle is “locked” in the bronchial wall mucosa. This way it will not dislocate 
very easily. See diagram below.
After, the tip of the needle is bent towards the bronchial wall and simultaneously 
the bronchoscope and sheath are pushed forward. This way, extra force can be 
delivered to assist penetration of the lymph node. A firm hand and self-confidence 
can be very helpful performing this manoeuvre.
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7) Aspiration after lymph node puncture
After successful penetration of the lymph node, a vacuum is obtained with a 60 
ml syringe at the end of the sheath. In the MW 319 needle this entails a separate 
syringe that is screwed on the sheath. In case of the Boston eXcelon needle, a 
built-in and lockable syringe is used. When the plunger is pulled back and rotated 
90 degrees, the plunger remains in vacuum position. 
The amount of restraint that is felt on the plunger gives an estimate on the 
amount of vacuum that is achieved. The experience built up in this thesis warrants 
the assumption that the amount of negative pressure that is achieved can be 
predictive of TBNA yield. That is, when no vacuum is felt by the nurse, needle 
position has to be re-evaluated and if necessary the needle has to be removed 
and replaced.
With vacuum in progress, the needle is jabbed back and forth a few times and 
the tip of the scope is wiggled up and down. This has to be done with care, as 
not to dislocate the needle. The exact number of times the needle has to be 
jabbed up and down is unknown, which also goes for the wiggle of the tip of the 
bronchoscope.
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The next step is the release of vacuum, which happens in the eXcelon needle 
automatically when the needle is withdrawn in the sheath. In case of the MW 319 
needle, vacuum has to be released first before the needle is with drawn.
Finally the sample is expelled into a vial from the needle by airflow and flushing, 
using the same syringe. Histology samples are separated and stored in a different 
vial for further preparation.
34
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CHAPTER 3
Diagnostic Yield of Transbronchial Histology Needle Aspiration in Patients 
with Mediastinal Lymph Node Enlargement
F. H.W. Hermens, T. C.A. Van Engelenburg, F. J. Visser,
F. B.J.M. Thunnissen, A. Termeer, J. P. Janssen
Respiration 2003;70:631–635
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ABSTRACT
Background: Transbronchial needle aspiration (TBNA) is a safe, minimally invasive 
technique to assess the mediastinal spread of lung cancer. Excellent results 
have been published by experts. However, little information is available about the 
diagnostic yield of TBNA with the histology needle in a non-expert center.
Objectives: The aim of this study is to assess the diagnostic yield of histology 
TBNA in the workup of suspected lung cancer.
Methods: In a non-university teaching hospital, TBNA data from patients 
diagnosed with lung cancer between June 1998 and July 2000 were analyzed 
retrospectively. TBNA had been performed by six different bronchoscopists in 
patients eligible for surgery with accessible N2 and N3 lymph nodes on computed 
tomography of the chest during the workup of an undefined mass. Cytology and 
histology specimens were obtained with the same 19-gauge needle. TBNA 
results were considered to be diagnostic if cytologic or histologic examination 
revealed a malignant lesion or non-malignant lymphoid cells. However, TBNA 
outcome was called non-diagnostic if no representative cells were obtained.  
Results: From a group of 264 consecutive lung cancer patients, 106 (40%) 
patients were eligible for TBNA. In 79%, TBNA was diagnostic in cytology and/
or histology specimens. Malignancy was demonstrated in 59% (63/106). In only 
32/106 patients (30%), a histologic core of tissue could be sampled. In 87.5% 
of these patients (28/32), TBNA was diagnostic. For cytology only, this number 
was slightly lower (75%, 56/74).  In 12 cases, diagnostic TBNA was verified by 
mediastinoscopy: these diagnoses were concordant. The sensitivity is 65% if all 
non-confirmed cases are considered false negative. Ten mediastinoscopies were 
avoided because TBNA demonstrated contralateral N2 (= N3) disease. The routine 
use of TBNA during bronchoscopy in suspected N2 disease is a cost-effective 
procedure, as the total additional costs of TBNA (9,540 EUR) were lower than the 
costs of 10 avoided mediastinoscopies (15,500   EUR). No complications were 
observed.
Conclusion: The diagnostic yield of TBNA relied mainly on cytology specimens, 
despite the use of a histology needle. Representative histology specimens 
could only be obtained in 28/106 patients (26%).  Since TBNA was performed 
in a general hospital by different bronchoscopists, this procedure is useful in the 
workup of lung cancer patients with enlarged lymph nodes.
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INTRODUCTION
Transbronchial needle aspiration (TBNA) is a safe, cheap and minimally invasive 
technique in staging  patients  with lung cancer,  and can routinely be performed 
during a flexible bronchoscopy. Indications for TBNA are any  enlarged lymph 
nodes lining the trachea or main bronchi, ranging from  ipsilateral peribronchial 
and/or hilar nodes (N1) to ipsi-, contralateral and  subcarinal mediastinal nodes 
(N2 and N3) [1]. Accurate staging of the mediastinum is important for further 
treatment management. In case of N2 disease, surgical intervention is preceded 
by neoadjuvant chemotherapy. In case of N3 disease, surgical  intervention is 
not indicated. The ‘gold standard’ for preoperative histologic evaluation of 
enlarged mediastinal lymph nodes is mediastinoscopy. However, this procedure 
has certain disadvantages: it has to be performed under general anesthesia, and 
complications are rare but can be serious.
In 1983, Wang and Terry [2] adapted the TBNA technique originally described 
by Schiepatti in 1949 for use within the flexible bronchoscope. Nevertheless, 
the use of TBNA is all but widespread [3]. This may be due to lack of experience, 
accidental bronchoscope damage or failure to reproduce results reported by 
experts in the literature [4]. The aim of this study is to determine the diagnostic 
yield of TBNA in the workup of patients with lesions suspected for lung cancer in 
a non-university teaching center, routinely using the 19-gauge histology needle.
PATIENTS AND METHODS
All the patients suspected of having lung cancer between June 1998 and July 
2000 routinely underwent TBNA during a diagnostic bronchoscopy in case of 
enlarged accessible N2 lymph nodes on CT scan. In exceptional cases of small 
peripheral tumors, N1 lymph nodes (station 11) were sampled if this was 
thought to be the only way to obtain a diagnosis. All patients had undergone 
contrast CT prior to bronchoscopy, and the scan was available during the 
bronchoscopy. Patients who were no candidates for surgical treatment prior to 
bronchoscopy (poor performance status or lung function  precluding future lung 
surgery, suspected metastasis on CT or biopsy-proven extrathoracic metastases) 
were excluded from TBNA. Accessible, enlarged lymph nodes were defined as 
any node or group of nodes with a short axis ≥ 1 cm on CT, with a distance 
< 1 cm to the tracheal or bronchial wall. All six (full-trained) bronchoscopists used 
the same needle (MW 319 histology needles, Mill-Rose Laboratories, Mentor, 
Ohio, USA) to obtain histology and cytology samples. To avoid the chance 
of false-positive results due to contamination of malignant cells present in the 
bronchial secretions, TBNA was performed prior to brushings, washings or biopsy 
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specimens. After the identification of the most accessible target area on CT, the 
needle was positioned at the target site. A 20-cm3 syringe was connected to 
the catheter, and the needle was introduced to the node using the jabbing, 
piggyback, cough or the ‘hub against the wall’ method, described by Wang et 
al. [5] in 1997. After penetration, the inner needle was drawn back and suction 
applied with the syringe. In an attempt to free individual cells and/or tissue, the 
catheter was jabbed up and down, under different angles under continuous 
suction. After a few thrusts (usually 4–8), suction was released and the needle 
pulled back into the catheter. Subsequently, the catheter was removed from 
the bronchoscope, and the material was released out of the needle into an 
alcohol solution. The same syringe was used to apply pressure. Possible tissue 
fragments were separated from the cytology fluid and transferred to a vial with 
neutral buffered formalin.
This procedure was repeated up to a maximum of 3–4 times to collect enough 
material, if tolerated well by the patient. Finally, the puncture sites were checked 
for possible bleeding.
Definitions
The outcome of TBNA was categorized as diagnostic or non-diagnostic.   Results 
of TBNA procedures were defined as diagnostic malignant if malignant cells 
were unequivocally demonstrated during cytologic or histologic examination. 
Results were defined as diagnostic non-malignant if abundant benign lymphoid 
fragments were present, indicating that lymph nodes were sampled. In all other 
cases, the results were defined as non-diagnostic. Lymph nodes were localized 
on the CT scan according to the American Joint Cancer Committee classification. 
A simple approach was used to calculate the direct costs of TBNA and set 
against the benefit of avoiding further diagnostic workup.
Statistics
Because the majority of patients appeared not to be surgical candidates during 
the workup due to advanced disease, poor lung function/health status or small-
cell carcinoma, surgical confirmation of the TBNA diagnosis was only possible in a 
minority of patients. Consequently, the number of confirmed true-negative cases 
is limited. Therefore, sensitivity is calculated following a worst-case scenario; all 
non-malignant cases of TBNA without surgical confirmation are considered as 
false negative; besides, all non-diagnostic results are also considered as false 
negative.
Because of the limited information about true-negative cases, specificity was 
not assessed.
41
Diagnostic yield of transbronchial histology needle aspiration chapter 3
RESULTS
TBNA and Diagnosis
From a group of 264 lung cancer patients, 106 (40%) were eligible for TBNA 
during 2 years. In 71 patients (27%) TBNA was not performed because of stage I 
disease. The remaining 87 patients were not eligible for TBNA because they were 
no candidates for surgery already at the time of bronchoscopy due to poor lung 
function or distant metastases. For 84 of the 106 TBNA cases (79%), the procedure 
was diagnostic using either histology and/or cytology material. No complications 
were observed. The distribution of TBNA outcome for histology and cytology is 
shown in table 1. Malignancy was demonstrated in 59% (63/106). The relative 
contribution of different types of lung cancer was: squamous cell carcinoma in 
40%, adenocarcinoma in 17%, large-cell carcinoma in 14%, small-cell carcinoma 
in 26% and other in 3%. Cytology specimens were diagnostic in 75% (74/106). In 
only 32 patients, histology specimens could be sampled. In 28 (87.5 %) of these, 
TBNA was diagnostic. For cytology only, this number was 75% (56/74).
Table 1. Total number of diagnostic and non-diagnostic TBNA in 106 cases, 
subdivided by diagnosis based on histology, cytology or a combination of both 
procedures
Mediastinoscopy was performed in 18/106 cases (17%). In 10 patients (9%), 
mediastinal metastasis was considered proven by TBNA. The remaining 78 
patients were inoperable at the time of initial diagnosis because of advanced 
disease (stage III and IV), poor lung function or health status, of small-cell 
lung cancer. Consequently, these patients did not undergo mediastinoscopy. 
Comparison between the TBNA outcome and mediastinoscopy is shown in table 
2. In 1 of the 18 cases, a staging-relevant sampling error was detected: metastasis 
of carcinoma to lymph node with non-diagnostic TBNA. The diagnostic TBNA 
results for both malignant and non-malignant results corresponded to the results 
of mediastinoscopy, as the same nodes were sampled. Out of 21 diagnostic 
non-malignant TBNA procedures, 9 were confirmed through mediastinoscopy.
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Table 2. Comparison of TBNA outcome in 18 cases of NSCLC with mediastinoscopy
The remaining 12 were not verified by surgical biopsy. In a worst-case scenario, if 
all non-confirmed and all non-diagnostic cases are considered as false negative, the 
sensitivity is 65%. Ten patients were disregarded for primary surgical intervention 
because TBNA had shown malignant N2 lymph nodes. Table 3 shows TBNA 
according to stage. The sampled nodal stations are stratified for each stage 
separately.  In 1 patient data are missing. In 6 cases an N1 station was sampled.
Table 3. Number of TBNA procedures stratified by stage
For each stage, the numbers are categorized by nodal station. The data of 1 
patient are missing.
TBNA and Costs
The additional costs for TBNA compared to bronchoscopy alone are EUR 90. A 
mediastinoscopy costs EUR 1,550, including 2 days of hospitalization. The costs of 
a pathological analysis are the same for mediastinoscopy and TBNA and therefore 
not taken into account. The total costs for 106 TBNA procedures were (106 x 90) 
EUR 9,540.  The money saved by avoiding 10 mediastinoscopies was (10 x 1,550) 
EUR 15,500.
43
Diagnostic yield of transbronchial histology needle aspiration chapter 3
DISCUSSION
TBNA is a minimal-invasive way of tissue diagnosis of enlarged mediastinal lymph 
nodes on CT scan during the routinely performed flexible bronchoscopy in 
patients suspected of having lung cancer. Our study shows that in 59% of lung 
cancer patients with enlarged mediastinal lymph nodes, pathologic confirmation 
of suspected mediastinal metastasis was obtained by TBNA. The procedure was 
performed in a way to get as much material as reasonably possible. If larger 
fragments were obtained, these were used for histology; otherwise the material 
was only examined cytologically. Apparently, most of the collected material 
consisted of small fragments, and in only 26% of the cases representative histology 
specimens were available. The demonstration of lymph node metastasis in 59% 
of patients is comparable to the results achieved by Schenk et al. [6]. In their 
study, also performed with  a 19-gauge histology  needle, 64% of patients with 
proven malignant adenopathy were  diagnosed by TBNA. We started using the 
Wang histology  needle  in the beginning of 1997  and  started this  study  after 
a learning  curve  of almost 1 year. Even after our group became familiar with 
the TBNA procedure, the number of histologic cores of tissue sampled remained 
low, despite consequent use of the histology needle. However, we continued to 
use the 19-gauge histology needle, because the diagnostic yield of the 19-gauge 
histology needle is superior to the 22-gauge cytology needle, as demonstrated by 
Schenk et al. [6] and Harrow et al. [7].
An important question is whether a negative result is reliable if it is only confirmed 
by cytology but not by histology. This can only be answered by comparing 
TBNA results with the outcome of a mediastinoscopy or thoracotomy with surgical 
exploration of the mediastinum. In our study, TBNA results have been confirmed 
in 12 cases by mediastinoscopy from a total of 79 NSCLC patients. These results 
suggest that in our group of patients, lymph node metastasis at the TBNA target 
site appeared to be unlikely if non-malignant lymphoid cells were obtained by 
cytology only. However, a possible sampling error can never be excluded if the 
lymph node mainly consists of benign lymphoid cells and only a small fraction of 
metastases. False-negative results can therefore not be excluded. However, in the 
context of enlarged lymph nodes by mediastinoscopy, we expect beforehand 
that the enlargement in the majority of the patients with lung cancer without 
occupational disease is likely to be due to metastases. The one patient who was 
TBNA negative but appeared to be malignant after examination of the samples 
taken during mediastinoscopy was categorized as not  representative  (not 
diagnostic) because of the lack of a sufficient number of lymphocytes. Therefore, 
we think that technical aspects during the TBNA procedure may be the cause for 
the non-diagnostic cytologic diagnosis In the patients in whom the N2 status was 
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demonstrated by TBNA and mediastinoscopy was performed, it is questionable if 
mediastinoscopy should have been performed, if not to exclude N3 status. In our 
study we had 10 cases with potentially resectable lesions on CT (NSCLC) in whom 
TBNA confirmed a N2 or N3 metastasis. These were subsequently disregarded 
for primary surgical intervention. Therefore, in these cases, unnecessary 
mediastinoscopies were avoided. In a group of 85 patients in whom TBNA results 
were compared with mediastinoscopy results, Harrow et al. [7] only found one 
false-positive TBNA (specificity 99%). This is why we think that it is safe to 
withhold a mediastinoscopy if TBNA shows mediastinal spread of the tumor.
In our hospital, TBNA is performed during routine bronchoscopy in all eligible 
patients. By doing this, part of the patients who are subject to TBNA will appear 
to have SCLC or distant metastases during further workup. In these cases, the 
eventual use of TBNA may be limited. Considering the costs of 10 avoided 
mediastinoscopies, performing TBNA during a routine bronchoscopy is still 
cost-effective (EUR 9,540 for all 106 TBNA procedures vs. EUR 15,500 for 10 
mediastinoscopies).
Due to the recent success in positron emission tomography (PET) in assessing 
metastatic disease in lung cancer [8], the question arises which part TBNA can 
play in this context. Should mediastinoscopy still be performed if diagnostic 
TBNA and PET scan do not show metastatic lymph node disease in potentially 
resectable lung cancer? In the future, the combination of TBNA and PET scanning 
may reduce the number of mediastinoscopies. Prospective studies are needed to 
assess the role of PET scanning combined with TBNA.
In conclusion, using the histology 19-gauge needle, in 59% of all cases mediastinal 
lymph node metastasis was proven. In only 26% of all cases, representative 
histology specimens were obtained, and most diagnostic procedures rely on 
cytological material. Since TBNA was performed in a general hospital by different 
bronchoscopists, this procedure is useful in the workup of lung cancer patients 
with enlarged lymph nodes.
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ABSTRACT
Background: Transbronchial needle aspiration (TBNA) is a safe and minimally 
invasive technique in the assessment of patients with enlarged mediastinal lymph 
nodes. In this study, the diagnostic yield of a new transbronchial aspiration needle 
is examined.
Methods: At a nonuniversity teaching hospital, all consecutive patients with 
enlarged mediastinal N2 and N3 lymph nodes, accessible on computed chest 
tomography for TBNA, were selected prospectively. TBNA was performed with a 
19-gauge eXcelon transbronchial aspiration needle (Boston Scientific Corporation 
Natick, MA) by 5 different bronchoscopists. Cytology en histology specimens were 
obtained with the same needle. TBNA results were considered to be diagnostic if 
cytologic of histologic examention revealed a malignant lesion or non-malignant 
lymphoid cells. Otherwise, TBNA outcome was considered nondiagnostic, that is, 
no representative cells were obtained.
Results: In a total of 150 patients eligible for TBNA, 176 nodes were sampled. 
In 74% (130/176), TBNA was diagnostic in cytology and/or histology specimens. 
Malignancy was demonstrated in 69% (122/176). In 67/176 patients (38%), 
a diagnostic histologic core of tissue was obtained. Cytology was diagnostic in 
122/176 (69%). No complications were observed.
Conclusion: TBNA with the eXcelon transbronchial aspiration needle has a high 
diagnostic yield. Although originally developed for cytology specimen, adequate 
tissue for histologic examination is obtained in close to 40% of patients with high 
diagnostic yield. It is easy to use, mainly because of its simple design (without 
inner needle), and very sharp bevel.
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INTRODUCTION
The use of the transbronchial needle aspiration (TBNA) was first reported by 
Wang and Terry(1) in 1983. As the number of publications on TBNA on Pubmed 
is increasing, there were 60 publications between the years 1985 and 1990 and 
134 between the years 2000 and 2005. This can be explained by the ease of the 
procedure, low cost, low complication rate, and relatively high diagnostic yield, 
even in primary care centers.(2) This is in contrast to the endobronchial and 
esophageal ultrasound techniques both of which require expensive equipment 
and intensive training.
TBNA is indicated in patients with enlarged mediastinal lymph nodes abutting the 
trachea, subcarinal region, and main bronchi. Also, hilar nodes (N1) can often be 
reached. Adequate sampling of mediastinal nodes is important in staging of lung 
cancer, and can also provide other diagnoses, such as sarcoidosis, tuberculosis, 
etc. Various kinds of needles have been used, most of them a variant of the 
original needle developed by Wang. The one, which is designed to obtain histology 
specimen (MW-319) entails a simple catheter with inner and outer needles, which 
penetrates the lymph node. With a vacuum system, material can be aspirated 
from the enlarged node for cytology and histology specimen. Recently, a new 
aspiration needle has been developed for sampling of cytology specimens only 
(eXcelon, Boston Scientific, Boston, USA) with the claim that it is easier to use 
and could provide high diagnostic yield. A prospective study was undertaken tot 
assess the utility of this new needle in patients with enlarged mediastinal lymph 
nodes.
PATIENTS AND METHODS
In a nonuniversity teaching hospital, consecutive patients with enlarged 
mediastinal lymph nodes, accessible for TBNA were included prospectively. 
Nodes were evaluated by chest computed tomography and were considered 
enlarged when the smallest diameter was > 1 cm. We routinely perform TBNA 
on all N2 and N3 lesions, and, if feasible also on N1 nodes. Patients with low 
performance scores, or with obvious metastatic (M1) disease werd excluded from 
TBNA, because N2 or N3 status does not alter the treatment in these patients. 
The new eXcelon aspiration needle was used (Boston Scientific, 19 Gauge) by 5 
different bronchoscopists. The study was conducted following approval by our 
institution’s research board.
The eXcelon needle is different in design from the Mill-Rose MW-319 needle. It is 
provided with a syringe at the proximal end that can be locked in vacuum position. 
This feature is to facilitate obtaining specimens by the bronchoscopy assistant 
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using his/her one hand (Figs. 1-3). Also, the vacuum is automatically released 
when the needle is retracted (Fig.2). Besides, the eXcelon needle has only one 
19-gauge needle, unlike the dual needle system of MW-319. The metallic needle 
has a very sharp bevel, which makes its insertion through the tracheobronchial 
wall very easy. At the proximal end of the needle catheter indicators are provided 
depicting the position of the needle, in relation to its distal end (in or out). The 
needle design also provides for locking the knob, which facilitates the movement 
of the needle- in or out position. This protective feature is to prevent inadvertent 
movement of the needle, during the passage through the working channel of the 
bronchoscope.
Figure 1. Proximal end of the needle catheter. Note the attached syringe, which 
can be maneuvered by the bronchoscopy-assistant using one hand.
Figure 2. Proximal end of the needle catheter. Note the ‘‘knob’’ locked in the 
‘‘needle-in’’ position.
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Figure 3. The knob locked in the ‘‘needle-out’’ position.
Interestingly, the distal portion of the catheter is flexible enough to drive the 
needle to the peripheral lesion, whereas its proximal segment is made stiff enough 
to deliver adequate force to push the needle through the tracheobronchial wall.
TBNA is performed before other investigations in the same bronchoscopy 
procedure such as biopsies, brush, etc, to minimize the chance of false-positive 
results. After identification of the target site, the eXcelon needle is introduced 
in the node, by using the jabbing, piggyback, cough, or “hub against the wall 
technique”, described by Wang(3) in 1995. The next step is the application of 
vacuum and thrusting the needle up and down, in an attempt to free individual 
cells or a core of the tissue. When the needle is retracted, vacuum is automatically 
released and the material is applied in an alcohol solution for further processing 
(Figs. 1-3). The same specimen is processed for histologic and also cytologic 
examinations depending upon the size of the aspirate. Aspiration is conducted to 
a maximum of 4 times per lymph node to recover enough material, if tolerated by 
the patient. Finally, the bronchoscopist evaluates the puncture sites for bleeding.
TBNA results were categorized in the following groups: malignant, non-malignant, 
or nondiagnostic. When benign lymphoid tissue was found in histology and/or 
cytology specimens, in the absence of malignancy, the results were considered 
“representative”. TBNA was considered nondiagnostic if no material was obtained 
or if the procured material was not representative, for example, in respiratory 
epithelial cells. In the category “diagnostic”, the malignant and non-malignant 
groups are combined.
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RESULTS
In a total of 150 patients eligible for TBNA, 176 nodes were sampled. In 74% 
(130/176), TBNA was diagnostic in either cytology and/or histology specimens. 
Malignancy was demonstrated in 69% (122/176). In 67/176 patients (38%), 
a diagnostic histologic core of tissue was obtained. Cytology was diagnostic in 
122/176 (69%). No complications were observed. The results, stratified for 
cytology and histology specimens are presented in Table 1. One case of Non-
Hodgkin lymphoma and 1 case of breast carcinoma are included in the total 
number of malignancies. In 4 cases, tuberculosis was diagnosed, all in histology 
specimens. 
Mediastinoscopy was subsequently performed in 18 (12%) patients with a non-
malignant outcome of TBNA. No false-negative results were noticed in these 18 
patients.
Table 1. Total number of diagnostic and nondiagnostic TBNA in 176 cases, 
subdivided by diagnosis based on histology, cytology, or a combination of both 
procedures
DISCUSSION
In the workup of a patient with mediastinal lymphadenopathy, tissue samples are 
necessary to establish a diagnosis or to evaluate the extent of the disease, such 
as in lung cancer. A minimally invasive, affordable, patient-friendly procedure is 
certainly preferred. TBNA has shown its value in this respect, but is still underused.
(4) In recent literature, emphasis lies in the esophageal ultrasound-guided fine 
needle aspiration or that by an endobronchial ultrasound. Good results have been 
reported, even in nodes where conventional TBNA failed to establish a diagnosis.
(5) However, ultrasound-guided needle aspiration is a more expensive procedure, 
requires extensive training and is only available in tertiary referral centers. 
Conventional TBNA can routinely be performed during a diagnostic flexible 
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bronchoscopy.(6) Another limitation regarding ultrasound-guided techniques is 
that, in most instances, specimen only for cytologic examination can be obtained
In this study, we present results using a new transbronchial needle. In the majority 
of patients (74%), valuable results are obtained using the eXcelon needle. We have 
previously reported a high yield using the Mill-Rose Wang 319 histology needles.
(2) In this study, TBNA was diagnostic in 79% of aspirated histology and cytology 
specimens combined. Cytology specimens were diagnostic in 75%, whereas in 
only 26% histology specimens were diagnostic. In the present study, histology 
was successful in 38% of all TBNA procedures. The overall result comparing the 
Mill-Rose needle with the eXcelon needle is the same, but the histologic yield is 
higher. Recently Oki et al(7) reported an unusual high diagnostic histologic yield 
of 94% using the previously mentioned 19-gauge MW-needle. In Oki’s study, the 
samples were microscopically reviewed and classified by size before processing, 
where even fragments 1 mm2 in size were processed for histology analysis. In our 
study, histology specimens were manually aspirated from the cytology vial, which 
could be easily performed without fragmentation, and processed separately.
This study indeed has several limitations: it was not a comparative trial, but 
results were compared with a previous study on TBNA using the MW-319 needle. 
The size of thy lymph nodes was not considered in relation to the diagnostic yield. 
However, all patients with mediastinal lymph node enlargement were included 
in this study and no patients were excluded from analysis after bronchoscopy. 
Therefore, we believe the results to be representative for all patients with lymph 
node enlargement. A large number of our patients had malignant disease. The 
diagnostic yield of TBNA is higher in aspiration of enlarged lymph nodes due to 
malignancy, which may have had a positive influence on the results. As very few 
of our patients with negative TBNA underwent mediastinoscopy, we are unable 
to provide accurate false or true negative results and hence further statistical 
analysis.
Obtaining histology is of great importance, especially in granulomatous diseases 
such as sarcoidosis, tuberculosis, or other malignancies such as malignant 
lymphoma.(8) The advantage of large tissue fragments is that additional testing 
can also be performed, such as immunohistochemistry, if required. Larger pieces 
of tissue can also help identify primary site of malignancy in case of metastatic 
lung lesion. (9,10) The value of obtaining histology over cytology alone has been 
investigated and discussed by other authors. (7,11-13)
In conclusion the new eXcelon transbronchial aspiration needle is easy to use and 
has a comparable diagnostic yield combining histology and cytology specimens. 
The new needle provides tissue for histologic examination in higher number of 
aspirates yet, its overall yield is similar to the older needles
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ABSTRACT
Background: Despite its proven efficacy, transbronchial needle aspiration (TBNA) 
remains an underutilized technique for sampling enlarged mediastinal lymph 
nodes in the staging of lung cancer. Previous investigators have reported on TBNA 
experience, but without mentioning individual learning curves related to lymph 
node size in pulmonologists experienced in bronchoscopy. 
Objectives: The aim of this study was to evaluate the TBNA learning curve in a 
group of pulmonologists already experienced in bronchoscopy, and to relate their 
yields to lymph node size and location. 
Methods: Data on TBNA yield and related lymph node size were collected 
retrospectively for five individual pulmonologists. 
Results: The diagnostic yield of five pulmonologists who started to perform TBNA 
was evaluated over the first 32 months. TBNA was performed on 138 lymph nodes 
in 119 patients. The overall diagnostic yield was 77% (range 67-91%). The average 
diagnostic yield increased from 77% at the start of the learning curve to 82% after 
32 months of experience. It was related to lymph node size, but not to lymph 
node location. The average lymph node size was 22 mm.
Conclusions: Satisfactory results were obtained immediately after introduction 
of TBNA in the bronchoscopy workup. There is no significant TBNA learning 
curve. The diagnostic yield was related to lymph node size but not to lymph node 
location.
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INTRODUCTION
In patients suspected of having lung cancer with mediastinal lymph node 
enlargement, a pathological diagnosis of those lymph nodes is essential. In 
recent years, transbronchial needle aspiration (TBNA) has proven to be a safe, 
minimally invasive, cost-effective technique to obtain tissue for diagnosis with a 
relatively high diagnostic yield [1-4]. More recently, ultrasound-guided techniques 
like esophageal ultrasound-guided fine needle aspiration and endobronchial 
ultrasound have stolen the limelight from TBNA [5-7]. These approaches, however, 
require special training, experience and considerable finances and subject the 
patient to a further procedure besides the routine bronchoscopy included in the 
primary workup for every patient. 
In our opinion, every patient with mediastinal lymph node enlargement should 
undergo TBNA during the initial bronchoscopy. It is therefore interesting to 
determine the TBNA learning curve in otherwise experienced pulmonologists in 
order tot estimate how fast an adequate yield can be accomplished.
Previous investigators have reported on TBNA experience, but without mentioning 
individual learning curves related to lymph node size in otherwise experienced 
pulmonologists [8,9]. The aim of this study was to assess the TBNA learning curve 
for experienced pulmonologists.
PATIENTS AND METHODS
In our non-university hospital, we have performed TBNA since October 1997 
according to the detailed description of Wang [10]. Five different pulmonologists 
(A-E) started performing TBNA in consecutive patients presenting with mediastinal 
lymph node enlargement in an auto-educational setting, and all bronchoscopists 
commenced TBNA training at the same time, since every bronchoscopist has his 
own session in theatre on a set weekday (Monday to Friday). No specific training 
or hands- on courses were followed and none of the bronchoscopists had any 
previous experience with this technique, except bronchoscopist B, who had 
limited experience in TBNA before the study period (<10 procedures).
All patients received chest CT, in order to be able to assess lymph node size. CT 
was reviewed by both pulmonologists and radiologists, but the pulmnologist 
decided on which of the nodes TBNA was performed or not. Nodes were 
considered enlarged when the smallest diameter was >1 cm. We routinely 
perform TBNA on all N2 and N3 lesions, and in rare cases also on N1 nodes. TBNA 
is performed using a technique described previously [2]. Rapid on-site cytology 
was not available. TBNA was performed with the histology needle developed 
by Wang(MW 319 needles, Mill-Rose Laboratories, Mentor, Ohio, USA). TBNA 
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results were categorized into the following groups: malignant, non-malignant or 
non-diagnostic. In the case of malignancy, this was observed in histology, cytology 
or both specimens. When benign lymphoid tissue or normal lymphocytes were 
found is histology and/or cytology specimens, in the absence of malignancy, the 
results were considered representative. Representative non-malignant samples 
and malignant results were considered diagnostic TBNA. TBNA was considered 
non-diagnostic if no material was obtained or if the procured material was not 
representative. Diagnostic yield is defined as all diagnostic TBNA divided by the 
corresponding total number of TBNA.
Lymph node location was described according to the classification of Mountain 
and Dressler [11]. The diagnostic yield in the first 16 months (period 1) was 
compared to the diagnostic yield in the last 16 months (period 2).
RESULTS
Between October 1997 and July 2000, five different bronchoscopists performed 
TBNA on 138 lymph nodes in 199 patients. No complications were observed. 
In 67-91% of all TBNA procedures performed by the different pulmonologists, 
aspiration was successful, resulting in a malignant diagnosis or representative 
benign lymphoid tissue. More importantly, in 52-76% malignancy was observed, 
proving N2 or N3 status. In 10 cases, data on node size are missing. Table 1 shows 
results according to the individual pulmonologist with histological, cytological 
and total diagnostic yield. Average lymph node sizes and yield according to lymph 
node size are listed in table 2. The diagnostic yield was not related to lymp node 
location (data not shown).
Table 1. Results for pulmonologists A–E
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Table 2. Overall yield according to lymph node size
Figure 1 depicts separate malignancy yields for each pulmonologist, as a function 
of lymph node size, with higher success rates in larger nodes. The increase in the 
diagnostic yield from period 1 to period 2 is shown in figure 2. During the study 
period, yields increased in all pulmonologists, with the exception of one. Average 
lymph node size increased from 19.2 to 24.5 mm in periods 1 and 2, respectively.
Fig. 1. Percentage of malignant cases according to lymph node size. Pulmonologists 
A, B, C, D and E assessed 3, 15, 13, 17 and 20 nodes ≤ 20 mm and 6, 12, 10, 13 and 
19 nodes ≥ 21 mm, respectively.
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Fig. 2. Yield for each pulmonologist in both periods. 5, 14, 13, 17 and 22 nodes were 
assessed in period 1, and 4, 14, 12, 16 and 21 nodes in period 2 by pulmonologists 
A, B, C, D and E, respectively.
DISCUSSION
TBNA has become established as a reliable, safe and minimally invasive technique 
to obtain material for tissue diagnosis in patients with enlarged mediastinal 
lymph nodes. Since its first introduction through the flexible bronchoscopy by 
Wang and Terry [12] in 1983, TBNA had not gained worldwide acceptance due 
to irrational thoughts about possible complications, inability to reproduce high 
yields reported in the literature, fear of damaging the bronchoscope and unjust 
beliefs about a long learning curve [13].
In recent years, ultrasound-guided endoscopic needle aspiration has been 
introduced. The reported diagnostic yield ranges from 80 to 96% depending on the 
study design and the technique applied [5]. Although many authors report higher 
yields with ultrasound techniques compared to TBNA, this is not necessarily true 
for all lymph node sites [14]. In a recent study, Bernasconi et al. [15] have reported 
excellent results combining TBNA and positron emission tomography in patients 
that were not subjected to endobronchial or esophageal ultrasound, suggesting 
TBNA and PET are complementary and can reduce the need for mediastinoscopy.
The aim of this study was to evaluate the learning curve of TBNA for experienced 
bronchoscopists. Some authors mentioned a troublesome, long learning curve 
without reference to the literature [7.14]. Rodríguez de Castro et al. performed a 
prospective study investigating the learning curve of only a single bronchoscopist 
over time, without relating the yield to node size [16], and quoted a minimum of 
50 TBNA procedures to achieve results reported in the literature, but this result is 
based on only one learning curve. Haponik et al. [17] performed a retrospective, 
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larger study on 14 bronchoscopists , including eight fellows under supervision. 
This study was confounded by a very heterogenic group of bronchoscopists 
with differences regarding experience, training, the kind of needles used and 
the preparation of specimens, and CT was not always applied to guide TBNA. In 
addition, the results of this study were related to lymph node size. The study by 
Hsu et al. [18] has the same limitations.
In this study, we report the individual results of five bronchoscopists with 1- to 
18- year experience before performing TBNA. In contrast to previous reports, we 
did not find a long learning curve. All bronchoscopists received similar results 
concerning histological and cytological yields and percent malignancy proven in 
lymph node samples. The diagnostic yield was not related to lymph node location. 
In period 2, the average yield was slightly higher compared to period 1, but this 
increase can be fully explained by the larger node size that was sampled (19.2 mm 
in period 1 vs. 24.5 mm in period 2). Especially node >20 mm achieve a higher 
yield.
In conclusion, the diagnostic yield of TBNA was satisfactory in pulmonologists 
without previous TBNA experience. In contrast to previous studies, our results 
demonstrate that in experienced pulmonologists who started to perform TBNA 
during the routine workup of enlarged mediastinal lymph nodes, there is no long 
learning curve.
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ABSTRACT
Objective: Results from endoscopic needle aspiration [ transbronchial needle 
aspiration (TBNA), esophageal ultrasound-guided fine needle aspiration, real-time 
endobronchial ultrasound] mainly rely on cytology. We performed a retrospective 
study to evaluate the possible advantage of obtaining histologic samples during 
TBNA in the diagnostic assessment of mediastinal lymph node enlargement.
Materials and Methods: In a retrospective study 2 pathologists evaluated 
all TBNAs from patients with mediastinal lymph node enlargement in whom 
representative histologic en cytologic material was obtained, using only a histology 
needle. Cytology was reviewed before histology in a randomized, blinded fashion. 
Afterward, the results were related to the diagnosis made in the actual workup 
of the patient.
Results: A total of 50 TBNA’s were reviewed. In 86% (43 of 50), both pathologists 
made the same diagnosis on both specimens, or a difference in cytology and/or 
histology specimens did not alter the eventual treatment. In 14% (7 of 50) of all 
TBNAs, histology revealed a diagnosis according to at least 1 pathologist, which 
altered patient treatment.
Conclusions: Histologic material can reveal additional diagnostic information 
compared with sole cytologic examination in 14% of representative TBNA samples 
in patients with mediastinal lymph node enlargement. A discrepancy between 
cytologic en histologic TBNA results should prompt further investigation.
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INTRODUCTION
In recent years, several endoscopic techniques have been introduced to obtain a 
tissue diagnosis in mediastinal lymph node enlargement. Transbronchial needle 
aspiration (TBNA) was introduced by Wang and Terry in 1983.1  Esophageal 
ultrasound-guided fine needle aspiration and real-time endobronchial ultrasound 
fine needle aspiration have gained popularity, with the first publications dating 
back to the late 1980s of the previous century. Although these ultrasound 
techniques have shown high yields of up tot 96%, 2 these results mainly rely on 
cytology specimens.2,3 The question arises as to whether relying on cytology alone 
is safe. In transbronchial or transesophageal puncture techniques, it is unknown 
to what extent histology has an additional diagnostic value when compared with 
cytology alone. We conducted a retrospective, double-blinded, randomized study 
to answer this question.
MATERIALS AND METHODS
All consecutive TBNA procedures in our institution performed betweet August 
2004 en November 2006 were reviewed. All adequate TBNA specimens for which 
both cytology and histology material was available were included for analysis. 
TBNA was exclusively performed with histology needles: the dedicated histology 
needle MW 319 (Mill-Rose Laboratories, Mentor, OH) and, since 2005, the new 
eXcelon needle (19 gauge; Boston Scientific, Natick, MA). TBNA is routinely 
executed in all patients with mediastinal lymph nodes with a smallest diameter 
of > 1 cm as evaluated by chest computed tomography. The aspiration technique 
was performed as described before.4 TBNA was considered adequate when the 
obtained specimen showed malignancy or another specific diagnosis, or when 
normal lymphoid cells were present. Two pathologists reviewed all specimens 
in a random and independent way. First all cytology specimens were reviewed 
and afterward all histology was examined to prevent bias by judging cytology and 
histology from the same patient successively. The first author (F.H.) combined 
cytologic and histologic data afterward and related the results to the final diagnosis 
made in the actual workup of the patient. As this is a retrospective analysis of data 
obtained during routine medical practice without any additional interventions for 
research purposes, no specific approval of our Institutional Review Board was 
required.
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RESULTS
A total of 236 TBNA procedures were performed in our hospital from August 
2004 to November 2006. In 69 procedures (29%) no adequate TBNA specimens 
were obtained. In 167 procedures (71%) adequate TBNA material was obtained in 
cytology alone (110 procedures), in histology specimens only (7 procedures), or 
in both cytology en histology (50 procedures). In 86% (43 of 50) of these 50 TBNA 
procedures, both pathologists made the same diagnosis on both specimens. 
Of these 43 TBNAs, 86% (37 of 43) consisted of small cell lung carcinoma 
(SCLC) (7 of 43) or non-small cell lung carcinoma (NSCLC; 30 of 43). In the case 
of NSCLC, cytology defined the correct histotype (squamous cell carcinoma, 
adenocarcinoma, or NSCLC “not otherwise specified”) in 67% of cases, whereas 
histology gave the correct diagnosis in 93%. In 14% (6 of 43) normal lymphoid tissue 
or a granulomatous reaction was found and histology diagnosis was not superior 
to cytology. However, in 1 of these 6 cases, tuberculosis culture of a histology 
specimen alone resulted in the bacteriologic diagnosis of a Mycobacterium 
gordonae infection, whereas the culture of the cytologic specimen remained 
sterile. Of the remaining 5 patients, 3 had normal lymphoid tissue in their TBNA 
samples and were diagnosed with lymphadenopathy in the setting of a 
(nontuberculous) pulmonary infection. The 2 patients with granulomatous reaction 
were diagnosed with sarcoidosis. In 14% (7 of 50) of all TBNAs, by the judgment 
of at least 1 pathologist, histology findings altered patient management. Detailed 
results are given in Table 1. In 4 cases a different type of pulmonary carcinoma was 
found in histology material compared with cytology alone. In 1 case non-Hodgkin 
lymphoma was diagnosed and in 2 cases Mycobacterium tuberculosis was found 
by polymerase chain reaction (PCR) in histology specimens only, whereas PCR on 
cytologic material was negative.
TABLE 1. Results of Pathologists 1, 2, and the Actual, Final Diagnosis at Time of 
Patient Workup
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DISCUSSION
In the literature on endoscopic fine needle aspiration of mediastinal lymph 
nodes, the diagnostic yield obtained mainly relies on cytology. In most articles, 
reported yields are high, but rarely are the histologic and cytologic yields reported 
separately. 5 Needles used in these techniques are mainly developed for cytologic 
purposes and are usually 22-gauge. 3,6
Schenk et al7 conducted a study directly comparing 19-gauge and 22-gauge TBNA 
needles and showed that the 19-gauge needle has a significantly higher sensitivity 
compared with the 22-gauge needle. The latter showed false-negative TBNAs in 
up to 47% of all TBNAs. In addition, sensitivity of the 19-gauge histology results 
was higher compared with the 19-gauge cytology results (78.2% vs. 63.6%). 
More recently, Stratakos et al8 showed a 35.3% increase in the diagnostic yield 
for malignancy for histologic examination of TBNA samples, compared with sole 
cytologic examination. 
In view of these data, obtaining a histologic TBNA specimen increases the 
diagnostic yield. The question that arises, however, is whether relying exclusively 
on the cytologic TBNA material for an accurate diagnosis, in the case in which 
no histology is available, is wise. No specific literature is available to assess this 
question in TBNA material, although the value of obtaining histology over cytology 
for diagnostic purposes has been subject to debate, especially when a lymphoma 
or sarcoma is present.9,10
This study shows that in a significant number of samples, histologic material can 
be of additional diagnostic value over cytology alone, and not only in patients 
with lymphoma, as was the case in patient 3. 
In patients 6 and 7, PCR detection of M. tuberculosis was only positive on the 
histologic material. In patient 2, both pathologists recognized the presence 
of another tumor type in histology compared with cytology alone. Discrepant 
results in the case of a pulmonary malignancy were obtained in patients 1,4, and 
5. In all 3 cases, the final diagnosis was SCLC. Histologic material was incorrectly 
interpreted by1 or both pathologists as having a NSCLC component.
There are several limitations to this study that have to be addressed.
First, in clinical practice, TBNA results can be compared with other tissue samples 
obtained during the bronchoscopy procedure, such as bronchial biopsies, brushes 
en washings. In this study, the pathologist was only informed of the origin of 
the material, being fine needle aspiration from enlarged mediastinal lymph 
nodes mainly from patients suspected of having lung cancer, without additional 
information obtained from other diagnostic bronchoscopic procedures in the 
same patient. Furthermore, immunohistochemical staining of slides was not a 
part of the study procedure.
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Second, TBNA cytology material rarely produces a different diagnosis compared 
with histology in the same patient, unless a mixed-type tumor is present. One 
therefore might assume that the cytologic diagnosis could be changed after 
viewing histology (or the other way around), before a final judgment is given to 
the clinician. As both pathologists were not informed of the histologic diagnosis 
when evaluating cytology and vice versa, a biased judgment was prevented.
Third, the inherent heterogeneity of the lung cancer tissue must be taken into 
account. Stang et al11 performed a large histopathological evaluation study in 
which lung cancer cases diagnosed earlier were reviewed by several pathologists. 
Even in adequate histologic samples some interobserver variability is inevitable. 
This interobserver variability was larger in NSCLC compared with SCLC.
In conclusion, this study shows that the histologic material acquired with 
conventional TBNA can reveal additional diagnostic information compared with 
sole cytologic examination in 14% of representative TBNA samples. Relying solely 
on either cytologic or histologic samples results in case of discrepant TBNA results 
seems unjustified and should prompt further investigation to secure an accurate 
diagnosis.
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ABSTRACT
Background: Transbronchial needle aspiration (TBNA) is a safe, easy to learn, 
minimally invasive and affordable technique for staging of the mediastinum in 
lung cancer. It is, however, not routinely used during initial bronchoscopy.
The aim of this study was, to determine the number of mediastinal staging 
procedures (EBUS/EUS/mediastinoscopy) prevented by routinely using 
conventional TBNA during initial bronchoscopy. As a secondary outcome, cost 
savings were calculated. 
  
Methods: In our non-university teaching hospital, data for all patients diagnosed 
with lung cancer and pathologically enlarged mediastinal lymph nodes were 
analysed retrospectively, for a period of 4 years (August 2004 to August 2008).
All  patients underwent conventional TBNA during initial diagnostic bronchoscopy. 
The diagnostic yield of TBNA-results was determined. We assessed the number 
of mediastinal staging procedures (EBUS/EUS/mediastinoscopy), and associated 
costs, prevented by using TBNA.
Results: In 138 out of 265 (52%) patients, N2 (44%) or N3 (8%) disease was 
demonstrated using TBNA during initial bronchoscopy. None of these patients 
needed further mediastinal staging procedures. Potential cost savings were at 
least €100.000,-.
Conclusion: Conventional TBNA, employed during initial diagnostic bronchoscopy 
in the work-up of suspected lung cancer, precludes additional mediastinal staging 
procedures in >50% of patients and  substantially reduces health care costs. 
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INTRODUCTION
The treatment options for lung cancer are highly dependant on the stage of the 
disease. Mediastinal lymph node metastasis significantly reduces life expectancy 
and curative treatment options. Standard treatment for patients with mediastinal 
lymph node metastasis is chemo-radiation therapy.  
Early assessment of mediastinal metastasis by employing conventional TBNA 
during initial flexible bronchoscopy, has the potential to prevent further 
(expensive) staging procedures, such as ultrasound guided  endoscopy (EBUS/
EUS) and mediastinoscopy. 
Transbronchial Needle Aspiration (TBNA) is a safe, easy-to-learn, minimally 
invasive and affordable technique for mediastinal lymph node staging of lung 
cancer [1-7 ]. 
Despite these favourable properties, TBNA is not routinely used in initial 
bronchoscopy in the work up of lung cancer by all pulmonary physicians [7, 8].
The aim of this retrospective study was to determine the number of mediastinal 
staging procedures (EBUS/EUS/mediastinoscopy) prevented by routinely using 
conventional TBNA during initial bronchoscopy in the work up of lung cancer. 
As a secondary outcome, cost savings of prevented additional procedures for 
mediastinal staging (EBUS/EUS/mediastinoscopy) were calculated. 
MATERIALS AND METHODS
In our non-university teaching hospital, during initial bronchoscopy in the work 
up of suspected lung cancer, pathological mediastinal lymph nodes are routinely 
sampled using conventional TBNA. All patient underwent PET/CT scan prior to 
bronchoscopy. Mediastinal lymph nodes are considered pathological if the 
maximum short axis diameter on CT scan is equal to or exceeds 10 mm, and/or 
if lymph nodes show pathological uptake on PET scan. TBNA was performed as 
described before, using  the 19-gauge eXcelon needle [2]. Rapid on-site cytology 
was not available.
Medical records of consecutive patients, diagnosed with lung cancer between 
August 2004 and August 2008, were analysed retrospectively. Inclusion criteria 
were the availability of a CT-scan and PET-scan prior to bronchoscopy and a 
final pathological diagnosis of lung cancer. Exclusion criteria were the inability 
to undergo bronchoscopy and the presence of other easily accessible metastasis 
(supraclavicular or distant extrathoracic). 
Diagnostic yield was defined as all diagnostic TBNA (representative negative and 
positive, malignant samples) divided by the corresponding total number of TBNA. 
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TBNA diagnostic yield was determined according to cancer histology (SCLC or 
NSCLC) and lymph node diameter. 
Clinical follow-up data on further mediastinal staging procedures and treatment 
were collected for all patients.
The number of mediastinal staging procedures (EBUS/EUS/mediastinoscopy) 
prevented by routinely using conventional TBNA during initial bronchoscopy was 
determined and the associated cost savings were calculated. 
RESULTS
Diagnostic yield
In a total of 265 patients with mediastinal lymph node enlargement, 341 lymph 
nodes were sampled. The mean lymph node diameter was 19,8 mm (range 8 mm-
50 mm), respectively 18,2 mm (range 8 mm-50 mm) in NSCLC and 25,4 mm (range 
8 mm-42 mm) in SCLC. 
The diagnostic yield of TBNA was 75% (86% in SCLC, 72% in NSCLC). 
Metastatic disease was demonstrated in 257 out of 341 lymph nodes (75%). 
Histology specimens were positive in 133 out of 341 nodes (39%) and cytology 
specimens were positive in 246 out of 341 nodes (72%) (Table 1).
In 138 out of 265 (52%) patients N2 (44%) or N3 (8%) disease was demonstrated 
using TBNA during initial bronchoscopy. For NSCLC this was 92 out of 202 (45,5%) 
and for SCLC this was 46 out of 63 (73%) (Table 1). 
Table 1. Diagnostic yield of TBNA (subdivided by type of carcinoma) and number 
and percentage of confirmed N2/N3 disease (also subdivided by type of carcinoma).
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Follow up of the patients:
None of the patients  underwent further mediastinal staging procedures prior to 
treatment. 
One patient was diagnosed with a single node metastasis after initial bronchoscopy, 
but was not eligible for an operation, due to significant comorbidity, therefore no 
further mediastinal staging procedures were performed.
In one patient, treated for a presumed diagnosis of SCLC, based on cytology, 
subsequent mediastinoscopy performed due to unexpected non-responsiveness 
to chemotherapy showed NSCLC in histological lymph node samples.  
Of all 138 patients diagnosed and staged during initial bronchoscopy including 
TBNA, 27 underwent combined chemo-radiation therapy,  63 underwent palliative 
chemotherapy, 17 underwent palliative radiationtherapy and 33 received best 
supportive care (Table 2).
Table 2. Follow up and treatment of the 138 patients, diagnosed and staged 
during initial bronchoscopy (subdivided by type of carcinoma)
Costs of the procedure
The conventional TBNA needle, used in our setting, costs €110,- . Procedural 
costs are the same as for regular bronchoscopy without TBNA. An EBUS or EUS 
procedure, including sedation and admission to the day hospital, costs € 725,- . A 
mediastinoscopy, including general anaesthesia, costs €2450,-. If all 138 patients 
in whom N2 or N3 disease was demonstrated by concomitant TBNA during initial 
bronchoscopy would have undergone EBUS or EUS, the extra costs would have 
amounted to  €100.050,- . For 138 mediastinoscopy procedures this would have 
been €338.100,-.
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DISCUSSION
The incidence of lung cancer is rising. In the past decade, the increasing need for 
effective mediastinal staging procedures had been filled in by the introduction of 
costly endoscopic ultrasound guided techniques such as EBUS and EUS.  
Conventional TBNA is an affordable and safe procedure, which can be performed 
during  intitial bronchoscopy, which is routinely performed in the work-up of 
patients suspected of lung cancer. Nevertheless, the procedure never gained 
widespread popularity and may soon be abandoned with the recent introduction 
of ultrasound-guided mediastinal staging procedures. 
Our study demonstrates the diagnostic value and cost effectiveness of performing 
TBNA during intitial bronchoscopy.
After confirming N2 or N3 disease, no further mediastinal staging procedures 
were required before starting treatment in more than half of the patients. As a 
consequence, time from diagnosis to treatment is shortened considerably.
Since many patients with suspected lung cancer are old  and have often serious 
comorbidity,  these patients benefit from a rapid diagnosis and treatment plan 
with a minimum of hospital visits and invasive procedures.
The role of surgery in N2 disease is subject to controversy. Of the very heterogenous 
group of patients with preoperatively diagnosed N2 disease, only patients with a 
good performance status, a limited T status and a limited number of involved 
mediastinal nodes may benefit from surgery after induction chemo-radiotherapy 
[9].
In our study, single node  metastasis was found in only one patient, but the patient 
wasn’t operable due to comorbidity, so no complementary mediastinal staging 
procedures were performed.
CONCLUSION
Conventional TBNA employed during initial diagnostic bronchoscopy in the work-
up of suspected lung cancer precludes additional mediastinal staging procedures 
in more than 50% of patients and substantially reduces health care costs. In 
addition to cost reduction, the time from diagnosis to treatment is reduced, 
which also makes the concomitant TBNA during the initial bronchoscopy more 
patient-friendly.
Conventional TBNA remains a useful and cost-effective procedure in patients 
suspected of lung cancer with pathologically enlarged mediastinal lymph nodes 
and should not be abandoned, but can be routinely performed during the initial 
diagnostic bronchoscopy in the work-up of suspected lung cancer.
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SUMMARY
Transbronchial Needle Aspiration has proved to be a safe, simple and cheap 
technique to assess mediastinal lymph node enlargement. Not only in patients 
suspected of having lung cancer, but also other malignant or benign abnormalities 
such as malignant lymphoma, tuberculosis, sarcoidosis, and even Pneumocystis 
Jirovecii and cryptococcal infections in patients with AIDS have been successfully 
diagnosed by means of TBNA (1-3). In patients with lung cancer, mediastinal 
staging is of cardinal importance, since it determines not only treatment options, 
but is decisive in patient prognosis (6). Complications in TBNA are scarce and only 
scant reports are published (4,5,9). 
Despite the advantages TBNA has in the work-up of patients with lung cancer, it 
is relatively underused because of unjust beliefs about complication rates, fear of 
a long learning curve or risk of damaging the bronchoscope (7,8). In recent years 
publications on TBNA have drastically diminished in favour of new ultrasound 
techniques such as endobronchial ultrasound (EBUS) and esophageal ultrasound 
(EUS) fine needle aspiration. These techniques in relation to conventional TBNA 
will be discussed later in this paragraph.
The number of published papers (pubmed search) for conventional transbronchial 
needle aspiration and endobronchial ultrasound fine needle aspiration (EBUS-
FNA) in the last decades are shown in the figure below.
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This thesis tries to underline the advantages of this simple technique, first by 
showing in chapter 3 that in a non-university setting, yields are very high. In a 
total of 106 patients, TBNA showed a diagnostic result in 84 (79%) cases, of which 
63 (59%) showed malignancy. In this series 10 mediastinoscopies were avoided 
because TBNA showed N2 disease, making the patient unfit for primary surgical 
intervention. The chance of false-positive TBNA is considered to be very low, 
which has been investigated earlier in a study by Harrow et al, showing only one 
false-positive TBNA in a group of 85 TBNA verified by mediastinoscopy (9). In our 
study, 18 TBNA (17%) were verified by mediastinoscopy, showing no false positive 
or false negative TBNA in diagnostic TBNA. One staging relevant sampling error 
was seen, but in a non-diagnostic TBNA. In an extensive review of mediastinal 
staging procedures, which has been incorporated in the ACCP Guidelines on the 
Management of Lung Cancer, Detterbeck et al. have published an excellent review 
on this matter (33). A total of 17 studies have been collected (the present article 
included) involving 1339 TBNA. In 16 of these studies, specificity was 100%. Only 
one study showed a specificity of 96%, but this was performed with a 22 Gauge 
cytology needle. 
Another very important remark that has to be made when interpreting the data 
of the study in chapter 3, concerns the fact that data collection in this study was 
performed between 1998 and 2000, which was a time where PET scanning was 
not incorporated in the standard work-up of patients with lung cancer. In several 
studies, the use of PET prior to diagnostic TBNA has been shown to not only 
increase yield, but also suggesting a 100% sensitivity when combining PET and 
TBNA, discarding the necessity of further diagnostic procedures (39).
 We believe these data underline the usefulness of this technique in the routine 
work-up of lung cancer patients. Although a 19-gauge histology needle was used, 
diagnostic histology was only obtained in 26% of all TBNA. At the time of the 
study, the Mill-Rose Wang 319 histology needles were used in our hospital, which 
were equipped with an inner and outer needle. The inner needle was designed to 
prevent plugging of the outer needle by bronchial tissue, before the lymph node 
was penetrated. 
Later, the eXcelon® needle was available for routine TBNA through regular 
bronchoscopes, which has been discussed in chapter 4. The eXcelon needle is 
different in design from the needle used in chapter 3. It is provided with a syringe 
at the proximal end that can be locked in vacuum position. This feature designed 
is to assist the aspiration of specimens, by applying suction on the lymph node. 
Also, the vacuum is automatically released when the needle is retracted. In a very 
inventive study by Boonsarngsuk et al, a comparison is made between TBNA in 
which suction is applied by a nurse manually retracting the plunger of the syringe, 
compared to a self-made device in which the plunger is locked in vacuum position 
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without aid by a nurse (40). The developed system in this article is practically equal 
to the plunger-lock the eXcelon needle is equipped with. No difference in yield 
was observed. However, having a plunger-lock does enable the nurse to assist the 
bronchoscopist in the various techniques described in Chapter 2, making it still 
very useful in performing TBNA.
Besides, the eXcelon needle has only one 19-gauge needle, unlike the dual needle 
system of the MW-319. The metallic needle has a very sharp bevel, which makes 
its insertion through the tracheobronchial wall very easy. This was not the primary 
goal of this study, but all bronchoscopists felt penetration of the bronchial wall (or 
even tracheal cartilage) was easier compared to the MW-319 needle. The fact 
that this needle is not equipped with an inner needle to prevent plugging of the 
outer needle with bronchial mucosa did not seem to be a factor of importance 
gaining adequate yield. A literature search regarding this subject did not reveal 
any hit in Pubmed. The author therefore concludes that the dual needle system 
developed by Wang and Mill Rose Factories was based on logic reasoning and not 
on evidence gained in randomized studies. 
In a total of 150 patients eligible for TBNA, 176 nodes were sampled. In 74% 
(130/176), TBNA was diagnostic in either cytology and/or histology specimens. 
Malignancy was demonstrated in 69% (122/176). In contrast to the needle used 
in chapter 3, this needle performed better in obtaining histology material. In 
67 lymph nodes (38%), a histological core of tissue was obtained. We believe 
this result to be explained by a more bevelled needle which penetrates the 
tracheal wall easier, the absence of an inner needle and the suction device at the 
proximal end. These assumptions were not investigated further in this study. In 
18 patients mediastinoscopy was performed in non-malignant TBNA, showing no 
false-negative results. Obtaining histological material is important, especially in 
granulomatous diseases such as sarcoidosis, tuberculosis, or malignant lymphoma. 
The advantage of large tissue fragments is that immunohistochemistry can also be 
performed if required. Larger pieces of  tissue can also help identify the primary 
site of malignancy in case of metastatic lung lesions (10-15). 
In chapter 5 we investigated the learning curve of TBNA. As stated before, fear 
of a long or troublesome learning curve withheld many bronchologists from 
performing TBNA (16, and unpublished data). The learning curve of TBNA 
has not been investigated before in this manner. Only reports on personal 
experience, without individual learning curves have been published (17,18). In 
this study we show the learning curve of five different bronchoscopists with 1- 
to 18-year experience before performing TBNA between two different points in 
time. In contrast to previous reports, we did not find a long learning curve. All 
bronchoscopists received similar results obtaining histological and cytological 
yields. Also, the percentages in diagnostic malignant TBNA were similar between 
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bronchoscopists. Diagnostic yield was not related to lymph node location, but was 
related to lymph node size. In the second period investigated, the average yield 
was slightly higher compared to period 1, but this increase can be fully explained 
by the larger node size that was sampled (19.2 vs. 24.5 mm). Especially nodes 
greater than  20 mm achieve a higher yield. This led us to the conclusion that 
TBNA can be learned quickly and fear of long learning curves are unjustified. 
Despite these findings, only 11-30% of pulmonologists use TBNA as a first line 
diagnostic tool in mediastinal lymphnode enlargement (42). The most frequent 
reasons mentioned for this underutilisation are problems with the technique, lack 
of on site cytopathology and lack of faith in the usefulness of TBNA (7). The cause 
of these beliefs are discussed in the General Discussion further in this paragraph. 
This thesis and chapter 5 in particular, disproves these unfounded beliefs and 
urges pulmonologists to abandon these prejudices. Even when a steady hand 
and self confidence are not present in an individual pulmonologist, the article by 
Davoudi et al might be helpful (43). In this study a high- and low-fidelity simulation 
training model have been investigated. Participants were subject to either a 
low-fidelity rubber trachea to exercise several TBNA techniques, or a high-end 
robotic device with simulation software. The results showed that instructors and 
participants both felt that the low-fidelity rubber training model was superior to 
the high-fidelity training robot in learning TBNA. Not investigated was whether 
this training was necessary in gaining adequate TBNA in the first place. No control 
group was introduced that immediately was thrown “into the deep” by starting 
(supervised) TBNA on actual patients. Chapter 5 suggests that this latter situation 
might be the preferred way to operate when training bronchoscopists in TBNA. 
When (unfounded) hesitation in using TBNA remains, a training model can off 
course increase self-confidence and stimulate TBNA use in general.
Chapter 6 was designed to assess whether a sole cytological result in TBNA is 
reliable if no other material is procured to help make a final diagnosis. In chapter 
4 we presented the histological yield of the eXcelon aspiration needle, which 
was higher than the older MW-319 needle, but still in only 38% of all TBNA 
with this needle a histological core of tissue was aspirated. As has been shown 
in the beginning of this paragraph, the use of endobronchial and esophageal 
ultrasound techniques have gained popularity in the last decade, at the cost of 
conventional TBNA. In contrast to TBNA, most EBUS and EUS procedures rely on 
cytology material, as this is mainly performed with 22-gauge cytology needles 
(3,19-22). The question arises as to whether relying on cytology alone is safe. In 
transbronchial or transesophageal puncture techniques, it is unknown to what 
extent histology has an additional diagnostic value when compared to cytology 
alone. In this study, two pathologists reviewed histology and cytology from the 
same patients in a retrospective, double-blinded and random fashion. 
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This study shows that in 7 out of 50 TBNA (14%) in which representative cytological 
and histological material was harvested, histology results revealed a different 
diagnosis compared to cytology, altering patient treatment. These results mainly 
entailed the diagnosis of a treatment-relevant different tumor type (NSCLC vs. 
SCLC), mycobacterium tuberculosis or lymphoma in histology specimens, not 
recognised in cytology alone. We believe this to be an important finding in 
interpreting TBNA (and EUS and EBUS) results. 
Besides, this study also showed that NSCLC-histotype yield improved from 67% in 
cytology to 93% in histology. At the time the paper was written and submitted for 
publication, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 
(TKIs) were subject of intense investigation and are now an established and in our 
opinion revolutionary new treatment option in EGFR positive adenocarcinoma. 
This was not the case at the time the study was performed. Taking this into 
account, the amount of treatment-relevant histology results are higher than the 
14% previously reported in the original publication. In addition, the selection of 
adenocarcinomas from the squamous cell carcinomas is also important because 
EGFR mutation analysis itself is mainly performed on histology, although cytology 
techniques are improving (23-25).
This thesis concludes with chapter 7, in which the cost-saving aspects of TBNA 
are studied. This subject has been shortly described in chapter 3 and more 
extensively in this chapter. We calculated a total amount of 338.100 euros to be 
saved with TBNA in a best case scenario, due to a 75% yield in which unnecessary 
endobronchial ultrasound techniques or mediastinoscopy are avoided. The 
assumption is made that all non-diagnostic TBNA would have been followed by 
EBUS procedures or mediastinoscopy. This will not be the case in all patients, as 
several factors can make the patient unfit for further mediastinal staging, such 
as distant metastasis or worsening performance status. We state that the cost-
argument is another reason for performing TBNA on a routine basis in the workup 
of patients with mediastinal lymph node enlargement and prevents unnecessary 
doctors-delay before treatment can be commenced.
GENERAL DISCUSSION
This thesis underlines the relative simplicity and added value of TBNA as a 
technique that can be performed at routine bronchoscopy, without extra costs or 
trouble for the patient. Despite these advantages, TBNA remains an underused 
technique as has been discussed before. In recent years new techniques have 
arisen in the diagnostic arena. Endobronchial ultrasound (EBUS) and esophageal 
ultrasound (EUS) fine needle aspiration are frequent subject of recent publications, 
but Computer Tomography (CT) fluoroscopic guided TBNA and electromagnetic 
navigation bronchoscopy are also matter of investigation (26, 27).  
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Ultrasound techniques such as EBUS and EUS have proven to show higher yields in 
mediastinal lymphadenopathy in comparison to conventional TBNA. Reports vary 
in diagnostic yields from 78% for EUS and 89%-93.5% for EBUS procedures, also 
depending on the use of positron emission tomography (PET) and CT scanning 
(19,21,28-30). Diagnostic results for conventional TBNA are as high as up to 79% 
as discussed in this thesis. Sensitivity and specificity for endobronchial ultrasound 
techniques are high, 90% and 97-100% respectively (21, 31). Sensitivity of 
conventional TBNA is 78,7% in a recent study, but may vary depending on several 
factors discussed later (32,33). Conventional TBNA specificity is almost invariably 
100% (33). 
Factors influencing the yield of TBNA have been studied comprehensively. One 
large factor is the use of Rapid On Site Evaluation (ROSE). This entails the presence 
of an on site cytopathologist, who will assess direct smears of TBNA aspirates on 
the presence of malignant material. This has proven to be a cost effective means 
of optimizing TBNA yield, by avoiding unnecessary aspirations or preventing the 
bronchoscopist to stop aspirating too early, but is only used in a limited number 
of papers on TBNA (34,35). The use of ROSE obviously demands intensive logistic 
adjustments in daily practice, which is not possible in every hospital. 
It has been studied before that the amount of aspirates per enlarged lymph node, 
as well as lymph node size, are of influence on TBNA yield (36-38). In discussing 
the use of TBNA and interpreting the many publications on this subject, one has 
to bear these factors in mind, when comparing efficacy of TBNA between articles. 
A pubmed search reveals only two papers discussing the optimal amount of 
passes through a lymph node (optimum amount is 4-6), while a bronchoscopist 
performing TBNA has to answer this question every time a node is sampled (37-
38). 
In the authors’ opinion, TBNA has been the subject of much debate the last few 
years. Results have been used by many authors in a manner familiar to Humpty 
Dumpty, where data can mean to individual authors exactly what they choose 
them to mean. Several studies have been published investigating TBNA in relation 
to other techniques such as EUS and EBUS, thicker and thinner needles, but also 
its’ value in other diseases like sarcoidosis, several infectious diseases, different 
types of tumors etc etc. Comparing the results of these studies is very hazardous 
because of the many different confounding factors between these studies. One 
study may show excellent yields in e.g. conventional TBNA, where another shows 
less optimal results in apparently comparable study-designs. We believe this to be 
based on several factors which are important in TBNA but only seldom investigated 
or mentioned in TBNA results. 
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One important factor is the number of needle passes per lymph node site as has 
been mentioned in the previous paragraph. Although a minimum of 4 passes is 
required for optimal TBNA yield, very few articles actually report on this matter 
when discussing TBNA results, often showing < 4 passes per site (27, 32, 35, 39). 
Another factor entails the type of needle used in these studies which vary from 
the 22 Gauge MW 122 needle to 18 Gauge histology needles (13, 27), where 
Gauge size is directly related to TBNA yield (15). A third feature hardly reported is 
the type of puncture technique used in these papers. As discussed in Chapter 2, 
several techniques are available and each bronchoscopist may have a preference 
for a technique, possibly influencing TBNA yield. No data are available on the 
question which technique produced optimal results. Fourth, the size of the lesions 
accessed is of direct influence on TBNA yield.
Finally, results are difficult to compare considering the various ways the obtained 
specimens are processed after TBNA. In an interesting report from Oki et al, TBNA 
samples were classified microscopically after being expelled from the needle 
(41). Samples were categorized in size 0-1 mm2, 1-2 mm2 and > 2 mm2 before 
processing. As can be expected, yield was directly related to sample size. No other 
report in TBNA has been published investigating this subject more extensively, 
which is surprising considering the fact that the vast majority of TBNA (and EUS / 
EBUS) articles focus on overall yield.
Key message of this paragraph is the wide variety of factors influencing TBNA 
yield, leading to a suspicious mind-set when judging TBNA papers.
TBNA IN THE ULTRASOUND ERA; A SECOND CHANCE FOR AN OLD FRIEND?
In the build-up of this thesis the author has had many discussions with 
pulmonologists from several countries, usually focussing on the matter of the 
new ultrasound techniques versus TBNA. The most often used argument is the 
fact that EBUS and EUS yields are in general higher compared to TBNA, which is 
an undisputed fact when reviewing the literature (except for an enlarged node 7). 
Every patient with mediastinal lymph node enlargement usually undergoes CT 
scanning and conventional bronchoscopy before further analysis (i.e. ultrasound 
FNA). Considering the fact that TBNA is used in conventional bronchoscopy, it 
should not be considered a substitute for EBUS or EUS procedures, but a method 
to prevent unnecessary extra procedures or doctors-delay. TBNA is performed 
during the initial bronchoscopy, generally performed in every patient suspected 
for lung cancer. When TBNA does not result in a satisfying answer on the cause of 
mediastinal lymph node enlargement, subsequent procedures (like EBUS or EUS) 
are indicated. Since TBNA specificity is 100% in the majority of studies, mediastinal 
staging is complete when a malignant result has been obtained, especially when 
TBNA provided enough tissue for molecular analysis (EGFR, KRAS). 
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Since 2011, the new CBO (Centraal BeleidsOrgaan) consensus on the diagnosis 
and treatment of NSCLC has been the primary guideline used in the Netherlands 
in the work-up of NSCLC patients. This guideline does mention the conventional 
TBNA but is primarily dealing with EUS-FNA and EBUS-FNA. Based on the data 
presented in this manuscript, we believe that conventional TBNA should be 
incorporated in every bronchoscopy together with brush, washing and biopsies 
when mediastinal lymph node enlargement is present. EUS-FNA and EBUS-FNA 
should be considered as a separate procedure that takes extra time, is patient 
unfriendly and costly. In general, only in case of a negative or non-conclusive 
TBNA the ultrasound techniques are indicated. In relatively recent state-of-the art 
studies concerning mediastinal staging with ultrasound techniques, often TBNA 
is not even mentioned in the Methods paragraph concerning the basic work-
up of the patient (44). This thesis shows that in a large part of the study-group 
mediastinal involvement would have been shown in the initial bronchoscopy with 
TBNA.
Although not part of this thesis, informal interviews with colleagues and an internet 
questionnaire held under Dutch pulmonologists showed that conventional TBNA 
was underused because of unjust beliefs about low yield, difficulty to perform or 
irrational fears of complications. These misconceptions have been contradicted 
by the results presented in this thesis. 
In order to improve patient care and reduce unnecessary diagnostic procedures 
a modified algorithm is proposed for all patients with mediastinal lymph node 
enlargement (see figure next page).
With this algorithm 52-59% of all ultrasound procedures can be avoided because 
TBNA demonstrated N2-N3 disease (45, 46). The cost savings in this algorithm 
are substantial considering a TBNA procedure during regular bronchoscopy costs 
110,- euro and EUS-FNA / EBUS-FNA 725,- euro (46). 
Implementing this algorithm is only feasible when all pulmonologists-in-training 
are familiar with TBNA and are adequately trained in this procedure.
It our firm belief that it is this high specificity in conventional TBNA that makes this 
procedure the optimal way to avoid unnecessary procedures for the patient. Since 
every patient suspected of having lung cancer is subject to bronchoscopy, TBNA 
is feasible for every bronchoscopist. It can be performed in the same procedure 
with very little effort and risk. In case of a positive i.e. malignant result, extra, 
expensive and time-consuming other procedures can be avoided.
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SAMENVATTING
Transbronchiale Naald Aspiratie (TBNA) is een veilige, eenvoudige en goedkope 
techniek om patiënten bij wie longkanker wordt vermoed te onderzoeken op 
uitzaaiingen in lymfeklieren in het mediastinum (het gebied tussen de longen, 
achter het borstbeen). En niet alleen longkanker, maar ook andere kwaadaardige 
of goedaardige aandoeningen zoals lymfklierkanker, tuberculose, sarcoïdose en 
zelfs zeldzame aandoeningen als Pneumocystis Jirovecii en Cryptococceninfecties 
bij patiënten met AIDS zijn succesvol onderzocht met TBNA bij patiënten met 
vergrote lymfeklieren (1-3). Bij patiënten met longkanker is de stadiëring van 
deze mediastinale lymfeklieren van vitaal belang, aangezien het de behandeling 
en de prognose bepaalt (6). Indien er uitzaaiingen zijn, kan er bijvoorbeeld zelden 
geopereerd worden. Complicaties van TBNA zijn zeldzaam en er zijn slechts enkele 
artikelen over gepubliceerd (4,5,9).
Ondanks de voordelen die TBNA biedt in de work-up van patiënten met 
longkanker, wordt deze techniek slechts weinig gebruikt vanwege wantrouwen 
over complicatierisico’s, de angst het niet te kunnen leren of angst om de 
bronchoscoop te beschadigen met de naald (7,8). De laatste jaren is het aantal 
publicaties over TBNA fors gedaald, ten faveure van nieuwe echografische 
technieken zoals endobronchiale echografische naald aspiratie (“endobronchial 
ultrasound”, EBUS) en echografische naald aspiratie via de slokdarm (“esophageal 
ultrasound”, EUS). De relatie tussen deze technieken en conventionele TBNA 
wordt later in dit hoofdstuk besproken.
Het aantal publicaties op Pubmed (de database op internet waar alle medische 
publicaties zijn terug te vinden) over conventionele TBNA in vergelijking tot EBUS 
in de laatste jaren zijn in onderstaande grafiek weergegeven.
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Dit proefschrift onderschrijft de voordelen van deze eenvoudige techniek, 
beginnend bij Hoofdstuk 3, waar getoond wordt hoe in een niet-universitaire 
situatie hoge opbrengsten gehaald kunnen worden. Op een totaal van 106 
patiënten wordt met behulp van TBNA een diagnose gesteld bij 84 (79%) patiënten, 
van wie een tumoruitzaaiing wordt gezien bij 63 (59%). In deze serie worden bij 10 
patiënten onnodige verdere onderzoeken zoals een mediastinoscopie vermeden, 
omdat TBNA al had aangetoond dat een operatie niet zinnig was gezien de 
lymfeklieruitzaaiingen. De kans op een fout-positieve uitslag wordt zeer laag 
geacht, wat al eerder is aangetoond door een publicatie van Harrow et. al. In 
deze studie liet men zien dat in een groep van 85 TBNA, die allen bevestigd waren 
door middel van een mediastinoscopie, er slechts 1 fout-positieve bevinding 
was bij de initiële TBNA (9). In onze studie werden 18 TBNA (17%) geverifieerd 
door middel van een mediastinoscopie, die geen fout-positieve of fout-negatieve 
resultaten liet zien in de groep van diagnostische TBNA. Er was één patiënt die een 
tumoruitzaaiing liet zien bij mediastinoscopie, waarbij de TBNA geen diagnose 
opleverde. 
Deze data onderstrepen het nut van TBNA in de routine work-up van patiënten bij 
wie longkanker wordt vermoed. Ondanks het feit dat een 19-Gauge histologische 
naald is gebruikt, werd in slechts 26% van alle TBNA daadwerkelijk histologie 
verkregen. Ten tijde van deze studie werden in ons ziekenhuis de Mill-Rose Wang 
319 histologische naalden gebruikt, die waren voorzien van een binnen- en 
buitennaald. De binnennaald was ontworpen om verstopping door bronchiaal 
weefsel te voorkomen, voordat de lymfeklier werd aangeprikt.
Later kwam de eXcelon ® naald op de markt voor routinegebruik in reguliere 
bronchoscopen, waarvan de resultaten worden besproken in hoofdstuk 4. De 
eXcelon naald heeft een ander ontwerp dan de naald uit hoofdstuk 2. Deze bevat 
een spuit aan het uiteinde die in vacuüm positie vastgezet kan worden. Deze 
noviteit helpt bij het losmaken van cellen en weefsel uit de betreffende klier, 
doordat een vacuüm wordt gecreëerd in de naald. Het vacuüm wordt automatisch 
opgeheven als de naald wordt teruggetrokken. 
In een inventieve studie door Boonsarngsuk et al, wordt een vergelijking gemaakt 
tussen een TBNA waarbij een verpleegkundige handmatig een vacuum aanbrengt 
met de spuit in de hand en een zelfgemaakt apparaat dat de zuiger van de spuit 
in een gefixeerde positie houdt zonder hulp van een verpleegkundige (40). Dit 
systeem is praktisch hetzelfde als het systeem van de eXcelon naald. Er werd geen 
verschil geobserveerd in deze studie. Toch is een spuit waarvan de zuiger gefixeerd 
kan worden dus een voordeel, aangezien de verpleegkundige nu een extra hand 
vrij heeft om de bronchoscopist te helpen zoals dat in hoofdstuk 2 beschreven is.
Daarnaast bevat de eXcelon slechts één 19-Gauge naald i.p.v. twee zoals in de Mill-
Rose Wang 319 histologische naald. Het metalen uiteinde van de eXcelon naald 
100
Samenvatting en discussiechapter 9
is uitzonderlijk scherp, wat penetratie van de tracheobronchiale wand aanzienlijk 
vergemakkelijkt. Dit onderdeel was niet het primaire doel van de studie, maar alle 
bronchoscopisten vonden deze nieuwe naald makkelijker dan de MW-319 naald, 
als het ging om de penetratie van de tracheawand (en zelfs de kraakbeenringen). 
Het feit dat deze naald geen binnennaald heeft om verstopping van de buitenste 
naald tegen te gaan had geen invloed op de opbrengst. Een zoektocht in de 
literatuur (Pubmed) over dit onderwerp liet geen relevante resultaten zien. 
Daarom concludeert de auteur dat het dubbele naald systeem van Mill Rose 
Factories is gebaseerd op een redenatie, maar niet op gerandomiseerde studies.
Op een totaal van 150 patiënten werden 176 lymfeklieren aangeprikt. In 
74% (130/176) was de TBNA diagnostisch in de cytologische of histologische 
preparaten. Maligniteit (kanker) werd in 69% (122/176) van de gevallen 
aangetoond. In vergelijking met de naald gebruikt in hoofdstuk 2, presteerde de 
eXcelon naald beter in het verkrijgen van histologisch weefsel. Bij 67 lymfeklieren 
(38%) werd een histologisch pijpje weefsel verkregen. Dit resultaat is ons inziens 
te danken aan de scherpere naald die makkelijker de tracheawand passeert, het 
uitblijven van de binnennaald en het vacuümsysteem aan het proximale uiteinde. 
Deze aannames zijn in deze studie niet verder onderzocht. In 18 patiënten werd 
een mediastinoscopie verricht, bij wie de TBNA een niet-maligne uitslag liet zien. 
Er werden geen vals-negatieve resultaten gezien. Het verkrijgen van histologisch 
materiaal is van belang, met name in granulomateuze ziekten zoals sarcoïdose, 
lymfklierkanker of tuberculose. Het voordeel van grotere weefselfragmenten 
bestaat uit de immunohistochemische bewerkingen die hierop gedaan kunnen 
worden, indien nodig. Histologisch materiaal kan ook behulpzaam zijn bij het 
identificeren van de locatie van de primaire tumor in het geval van metastasen 
van elders (10-15).
In hoofdstuk 5 is de leercurve van TBNA onderzocht. Zoals eerder is opgemerkt, 
weerhield de angst voor een lange of moeizame leercurve relatief veel 
bronchoscopisten hiervan gebruik van te maken (16, en ongepubliceerde data). 
De leercurve van TBNA is nooit eerder op deze wijze onderzocht. Er waren louter 
publicaties over persoonlijke ervaringen, zonder individuele leercurves (17,18). 
In deze studie laten we de leercurves zien van 5 bronchoscopisten met 1 tot 
18 jaar ervaring vóór het gebruik van TBNA tussen twee verschillende punten 
in de tijd. In tegenstelling tot eerdere publicaties was er geen sprake van een 
lange leercurve. Alle bronchoscopisten behaalden vergelijkbare resultaten 
voor wat betreft cytologische en histologische opbrengst. Daarnaast was het 
percentage diagnostische, maligne TBNA vergelijkbaar tussen de verschillende 
bronchoscopisten. De diagnostische opbrengst bleek niet gerelateerd aan 
lymfklierlocatie, maar aan lymfkliergrootte. In de tweede periode die bekeken is, 
was de gemiddelde opbrengst iets hoger ten opzichte van de eerste periode. Dit 
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verschil wordt echter verklaard door de gemiddelde grootte van de geaspireerde 
lymfeklieren, die in de tweede periode hoger lag dan in periode 1 (19,2 vs. 24,5 
mm). Met name klieren groter dan 20 mm lieten een hoge opbrengst zien. Wij 
concluderen dat TBNA relatief snel te leren is en dat de angst voor een lange 
leercurve onterecht blijkt te zijn.
Ondanks deze bevindingen, past slechts 11-30% van de longartsen TBNA toe 
als eerstelijns diagnostiek bij mediastinale lymfkliervergroting (42). De meest 
aangevoerde redenen om deze methode niet toe te passen zijn techiekproblemen, 
gebrek aan on-site cytopathologie en het gebrek aan vertrouwen in bruikbaarheid 
van TBNA (7). Oorzaken van deze visies worden verder besproken in de Discussie. 
Dit proefschrift en in het bijzonder hoofdstuk 5, bewijzen het tegendeel van 
deze ongegronde overtuigingen en zet longartsen ertoe aan hun vooroordelen 
los te laten. Zelfs wanneer een longarts geen vaste hand en zelfvertrouwen 
heeft, zou het door Davoudi geschreven hoofdstuk de helpende hand kunnen 
bieden (43). In deze studie wordt een meer en minder waarheidsgetrouw model 
onderzocht. Deelnemers moesten zowel TBNA-technieken oefenen op een 
minder waarheidsgetrouw rubberen trachea, als op een high-end instrument met 
simulatie-software. 
De resultaten lieten zien dat instructeurs en deelnemers beiden ondervonden dat 
bij TBNA-techniek het minder waarheidsgetrouwe rubberen oefenmodel beter 
voldeed dan het hoog waarheidsgetrouwe model. Er werd niet onderzocht of deze 
training noodzakelijk was om in eerste instantie adequate TBNA te verkrijgen. Er was 
geen controlegroep die gelijk “in het diepe werd gegooid” door (gesuperviseerde) 
TBNA bij daadwerkelijke patiënten toe te passen. Hoofdstuk 5 suggereert dat 
deze laatste situatie de voorkeur zou hebben wanneer bronchoscopisten in 
TBNA onderricht moeten worden. Indien ongegronde aarzeling om TBNA toe te 
passen blijft bestaan, zou een oefenmodel uiteraard het zelfvertrouwen kunnen 
vergroten en zo TBNA-onderzoek in het algemeen kunnen stimuleren.
Hoofdstuk 6 werd geschreven om de vraag te beantwoorden of een enkel 
cytologisch resultaat betrouwbaar is, als geen ander materiaal ter beoordeling 
voorhanden is om de diagnose rond te maken. In hoofdstuk 3 werd reeds de 
histologische opbrengst van de eXcelon naald gepresenteerd, die hoger bleek dan 
de eerder gebruikte Mill-Rose Wang 319 histologische naald, maar nog steeds 
slechts in 38% een daadwerkelijk pijpje weefsel produceerde. Zoals eerder in 
dit hoofdstuk is besproken, is het gebruik van echografische endobronchiale en 
transoesofageale technieken enorm toegenomen, ten koste van conventionele 
TBNA. Maar in tegenstelling tot gewone TBNA, resulteren EUS en EBUS meestal 
in een cytologisch resultaat, aangezien meestal de 22-Gauge cytologische naald 
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wordt gebruikt (3, 19-22). De vraag rijst of vertrouwen op alleen een cytologische 
uitslag betrouwbaar is. Bij de transbronchiale en transoesofageale echografische 
technieken is het onbekend in hoeverre histologie een additionele waarde heeft 
vergeleken met alleen cytologie. In deze studie hebben twee pathologen de 
histologie en cytologie van dezelfde patiënt op een retrospectieve, dubbelblinde, 
gerandomiseerde manier bekeken.
Deze studie laat zien dat in 7 van de 50 TBNA (14%) waarin representatief 
histologisch én cytologisch materiaal is verkregen, de histologische uitslag 
dusdanig anders was dan de cytologische, dat deze de behandeling van de patiënt 
wezenlijk veranderde. Het ging hierbij met name om een behandelingsrelevante 
verandering in tumor-type (kleincellig longkanker (SCLC) vs. niet-kleincellig 
longkanker (NSCLC)), tuberculose of lymfklierkanker in histologische specimens, 
die in de cytologie niet onderkend waren. We achten dit een belangrijke bevinding 
bij de interpretatie van TBNA (incl EBUS en EUS) resultaten.
Daarnaast verbeterde de subtypering van NSCLC van 67% in de cytologische 
preparaten naar 93% in de histologische preparaten. In de tijd dat deze studie 
werd aangeboden voor publicatie, waren de zogenaamde epidermal growth 
factor receptor (EGFR) tyrosine kinase inhibitors (TKI) onderwerp van gedegen 
onderzoek. Inmiddels zijn ze een – naar onze mening revolutionaire – nieuwe 
behandelmogelijkheid bij patiënten met een EGFR-positief adenocarcinoom. Dit 
was nog niet het geval in de tijd dat deze studie uitgevoerd werd. Wanneer we 
dit aspect meenemen in onze beoordeling van de resultaten, is het belang van 
het verkrijgen van histologie groter dan in de 14% genoemd in deze studie. Een 
ander argument in dit kader is het feit dat de bepaling van deze EGFR mutaties 
met name geschieden in histologisch materiaal, al zijn de cytologische technieken 
aan het verbeteren (23-25).
Dit proefschrift besluit met hoofdstuk 7, waarin de kostenbesparing als gevolg 
van het gebruik van TBNA wordt onderzocht. Dit onderwerp is reeds in hoofdstuk 
3 kort onder de aandacht gebracht, maar wordt in deze studie ruimer bekeken. 
Wij berekenden een totale besparing van 338.100 Euro door het gebruik van 
TBNA in een best-case scenario, aangezien de totale opbrengst van 75% onnodige 
EBUS procedures voorkomen heeft. Hierbij wordt aangenomen dat alle niet-
diagnostische TBNA gevolgd zouden zijn door een EBUS procedure. Het is onze 
overtuiging dat dit een extra argument is om TBNA routinematig te gebruiken bij 
patiënten met vergrote mediastinale lymfklieren.
DISCUSSIE
Dit proefschrift benadrukt de relatieve eenvoud en meerwaarde van TBNA, die 
als routine techniek gebruikt kan worden bij elke bronchoscopie, zonder extra 
103
Samenvatting en discussie chapter 9
kosten of extra ingrepen voor de patiënt. Ondanks deze voordelen is TBNA een te 
weinig gebruikte techniek zoals eerder uiteen is gezet. De laatste jaren zijn nieuwe 
technieken toegetreden tot de diagnostische arena. Endobronchiale echografische 
naald aspiratie (EBUS) en echografische naald aspiratie via de slokdarm (EUS) zijn 
frequent onderwerp van publicaties in medische tijdschriften, maar Computer 
Tomografie (CT) fluoroscopisch geleide TBNA en electromagnetische navigatie 
bronchoscopie worden in dit kader ook onderzocht (26, 27).
Echografische technieken zoals EUS en EBUS laten een hogere opbrengst zien 
bij mediastinale lymfadenopathie in vergelijking met conventionele TBNA. De 
totale opbrengsten variëren per publicatie van 78% voor EUS en 89-93,5% voor 
EBUS procedures, afhankelijk van het gebruik van positron emissie tomografie 
(PET) en CT scans (19,21,28-30). De diagnostische resultaten voor TBNA in het 
algemeen lopen op tot 79% zoals gerapporteerd in dit proefschrift. Sensitiviteit 
en specificiteit voor EUS en EBUS zijn hoog, 90% en 97-100% respectievelijk 
(21,31). De sensitiviteit voor conventionele TBNA is 78,7% in een recente studie, 
maar is afhankelijk van diverse factoren, zoals hieronder besproken (32,33). De 
specificiteit van TBNA is onveranderlijk in de meeste studies 100% (33).
Factoren die de opbrengst van TBNA beïnvloeden zijn uitvoerig onderzocht. 
Een zeer belangrijke factor is het gebruik van de zogenaamde Rapid On Site 
Evaluation (ROSE). Dit betreft de aanwezigheid van een patholoog, danwel een 
cytopathologisch laborant in de bronchoscopiekamer, die direct na aspiratie 
het materiaal beoordeelt op aanwezigheid van een eventuele maligniteit. Dit is 
een bewezen kosteneffectieve manier om de opbrengst van TBNA te vergroten, 
aangezien het voorkomt dat de bronchoscopist te vroeg ophoudt met aspireren. 
Deze techniek wordt slechts in enkele studies gerapporteerd bij TBNA (34,35). 
Het toepassen van ROSE vergt uiteraard veel van de lokale logistiek, die niet in elk 
ziekenhuis voorhanden is.
Ook het aantal aspiraties per lymfklier en de kliergrootte zijn van invloed op de 
opbrengst van TBNA en zijn uitvoerig bestudeerd (36-38). Als we het hebben over 
het gebruik van TBNA en de interpretatie van de beschikbare data, dan moet men 
deze factoren in het achterhoofd houden wanneer de resultaten tussen de diverse 
publicaties met elkaar worden vergeleken. Een zoektocht op Pubmed levert 
slechts twee publicaties op die het optimale aantal aspiraties (dit blijkt 4-6 te zijn) 
met TBNA per lymfeklier hebben onderzocht. En toch moet elke bronchoscopist 
zich bij elke TBNA afvragen hoe vaak hij of zij zal prikken.
Volgens de auteur is TBNA een veel besproken onderwerp de laatste jaren. 
Resultaten zijn gebruikt door vele auteurs zoals Humpty Dumpty uit het boek van 
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Lewis Carroll, waarbij gegevens door individuele auteurs worden uitgelegd naar 
eigen inzicht. Diverse studies zijn gedaan over onderzoek naar TBNA in relatie tot 
andere technieken zoals EUS en EBUS, dikkere en dunnere naalden, maar ook het 
belang ervan bij andere ziekten zoals sarcoïdose, verschillende infecties, diverse 
tumortypes etc.  Vergelijking van deze onderzoeksresultaten  onderling is risicovol 
vanwege de vele verwarrende factoren tussen deze onderzoeken. Het ene 
onderzoek kan bijvoorbeeld buitengewone opbrengsten van de conventionele 
TBNA laten zien, waar een ander onderzoek minder optimale resultaten in 
schijnbaar vergelijkbare studie-ontwerpen aantoont. Wij veronderstellen  dat 
dit is gebaseerd op diverse factoren die belangrijk zijn voor TBNA, maar slechts 
zelden onderzocht of genoemd worden in TBNA resultaten.
Een belangrijke factor is het aantal keren aanprikken per lymflier lokalisatie, 
zoals genoemd in het vorige hoofdstuk. Hoewel minimaal 4 keer aanprikken is 
vereist voor optimale TBNA-opbrengst, zijn er tegenwoordig ook enkele artikelen 
over TBNA-discussies die vaak < 4 keer aanprikken laten zien (27, 32, 35, 39). 
Een andere factor is het naaldtype dat in deze studies is gebruikt, variërend van 
22 Gauge MW 122 tot een 18 Gauge histologie-naald (13,27), waarbij Gauge-
grootte direct te maken heeft met TBNA-opbrengst (15). Een derde onderwerp 
waar nauwelijks over gesproken wordt, is de punctie-techniek. Zoals besproken in 
hoofdstuk 2, bestaan er diverse technieken en heeft elke bronchoscopist zijn/haar 
eigen voorkeur, mogelijkerwijs de TBNA-opbrengst beïnvloedend. Er zijn geen 
gegevens beschikbaar over de vraag met welke techniek de meeste optimale 
resultaten verkregen worden. Ten vierde, de grootte van de aan te prikken laesies 
is van directe invloed op de TBNA-opbrengst. 
Tenslotte, met betrekking tot de verwerking van het verkregen materiaal na TBNA 
zijn de resultaten ook moeilijk vergelijkbaar. In een interessant rapport van Oki et 
al werden TBNA-preparaten microscopisch geclassificeerd nadat ze van de naald 
verwijderd waren (41), en daarna (voor verdere bewerking) ingedeeld in groottes 
van 0-1 mm2, 1-2 mm2 en >2 mm2. Zoals reeds verwacht, stond de opbrengst 
in directe relatie tot de grootte van het specimen. In geen enkel ander TBNA-
onderzoek is dit uitgebreider onderzocht, wat opvallend is omdat het merendeel 
van TBNA (en EUS/EBUS) artikelen focussen op totale opbrengst.
Kernboodschap van dit hoofdstuk is dat er zeer veel factoren zijn die de TBNA-
opbrengst beïnvloeden, en dus artikelen over TBNA op meerdere manieren 
geïnterpreteerd zouden kunnen worden.
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TBNA IN HET ECHO-TIJDPERK; EEN TWEEDE KANS VOOR EEN OUDE VRIEND?
In de opbouw van dit proefschrift, heeft de auteur diverse discussies gevoerd 
met longartsen uit andere landen, doorgaans gefocust op de nieuwe ultrasound 
technieken versus TBNA. Het meest gehoorde argument is het feit dat EBUS- 
en EUS-opbrengsten over het algemeen hoger zijn dan bij TBNA, waarover na 
literatuurraadpleging ook geen discussie bestaat (behalve bij een vergrote klier 
op station 7).
Vaak ondergaat elke patiënt met een mediastinale lymfekliervergroting een 
CT-scan en een conventionele bronchoscopie alvorens verdere analyse ingezet 
wordt (i.e. EUS/EBUS FNA). In aanmerking genomen dat TBNA tijdens de 
conventionele bronchoscopie wordt gedaan, moet TBNA niet gezien worden als 
een vervanging voor EBUS of EUS procedures, maar als een manier om onnodige 
extra procedures of doctors’-delay te voorkomen. TBNA wordt gedaan tijdens 
de eerste bronchoscopie, meestal uitgevoerd bij elke patiënt die van longkanker 
wordt verdacht. Indien TBNA niet voldoende informatie geeft over de herkomst 
van de mediastinale lymfekliervergroting, dan is vervolgonderzoek (zoals EBUS 
of EUS) geïndiceerd. Aangezien TBNA een specificiteit heeft van 100% is de 
mediastinale stadiëring compleet indien een maligne resultaat wordt verkregen, 
in het bijzonder wanneer de TBNA-opbrengst genoeg is voor moleculaire analyse 
(EGFR, KRAS, ALK).
Sinds 2011 wordt de nieuwe CBO (Centraal Beleids Orgaan) consensus over 
diagnose en behandeling van NSCLC in Nederland als primaire richtlijn gebruikt 
in the work-up van NSCLC patiënten. Deze richtlijn noemt wel de conventionele 
TBNA, maar gaat hoofdzakelijk over EUS-FNA en EBUS-FNA. Terugkijkend naar de 
data uit dit manuscript, vinden wij dat conventionele TBNA bij elke bronchoscopie 
gedaan moet worden, tegelijkertijd met brush, spoelen en biopsie, indien 
lymfekliervergroting aan de orde is. EUS-FNA en EBUS-FNA zouden moeten 
worden beschouwd als een separate procedure die extra tijdrovend is, patiënt-
onvriendelijk en kostbaar. Over het algemeen zijn alleen echo-technieken 
geïndiceerd in geval van negatieve of non-conclusieve TBNA.  In relatief recente 
state-of-the-art studies over mediastinale stadiëring met echo technieken wordt 
TBNA zelfs niet genoemd in het Methoden hoofdstuk m.b.t. de basis work-up 
van de patiënt (44). Dit proefschrift toont aan dat in een groot gedeelte van de 
studiegroep mediastinale “betrokkenheid” zou kunnen zijn aangetoond in de 
eerste bronchoscopie met TBNA.
Hoewel niet in dit proefschrift opgenomen, bleek uit informele interviews en 
een internet enquête onder Nederlandse longartsen dat conventionele TBNA te 
weinig gebruikt werd om redenen van onjuiste opvattingen over lage opbrengsten, 
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uitvoeringsproblemen, of irrationele angst voor complicaties. Deze verkeerde 
veronderstellingen worden geopponeerd door de resultaten in dit proefschrift.
Om patiëntenzorg te verbeteren en onnodige diagnostiek te verminderen, 
wordt een aangepast algoritme voorgesteld voor patiënten met mediastinale 
lymfekliervergroting.
Volgens dit algoritme is 52-59% van alle EUS en EBUS procedures niet meer 
nodig, omdat TBNA N2-N3 ziekte aantoonde (45,46). De kostenbesparing met 
dit algoritme is aanzienlijk, aangezien een TBNA-onderzoek tijdens de reguliere 
bronchoscopie Euro 110,= kost tegenover EUS-FNA / EBUS/FNA Euro 725,= (46).
Implementatie van dit algoritme is slechts uitvoerbaar wanneer alle longartsen-
in-opleiding bekend zijn met TBNA en adequaat in deze procedure geschoold 
worden.
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Concluderend stellen wij dat het juist de hoge specificiteit van conventionele TBNA 
is, die deze procedure de optimale manier maakt om onnodige procedures bij de 
patiënt te voorkomen. Aangezien elke patiënt bij wie longkanker wordt vermoed 
een bronchoscopie ondergaat, is TBNA de uitgelezen manier om direct eventueel 
vergrote klieren te benaderen. Het kan in dezelfde procedure worden gedaan, 
met zeer weinig moeite en risico. In het geval van een positieve uitslag, in dit geval 
een maligniteit, worden andere dure en tijdrovende procedures voorkomen.
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ervaar bij jullie liefde, goedheid en begrip. Al 20 jaar lang. Dank daarvoor.
Anke, mijn lieve zus. We zien elkaar niet veel maar ik weet dat je er bent. En je 
bent er voor me als ik je nodig heb en daar ben ik je dankbaar voor! 
Beste Giel, uiteraard een apart woordje voor mijn beste zwager. Je bent een 
zwager uit duizenden. Ik had me geen betere kunnen wensen!
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Pa en ma, jullie staan onder aan deze lijst, maar eigenlijk horen jullie in grote 
letters op de voorpagina. Zonder jullie was ik niet wie ik nu ben. Met twee benen 
op de grond en alles wat ik me wensen kan. Jullie zijn mijn rots in de branding. Zo 
lang ik me kan herinneren staan jullie achter me en hebben me gesteund in alles 
wat ik deed. Ook in moeilijke tijden weten jullie me bij te staan en me de goede 
richting in te duwen. En ook nu staan jullie altijd voor mij, Tineke en de kinderen 
klaar als er weer opgepast moet worden of als er iets gerepareerd moet worden. 
Ik ben jullie dankbaar voor ALLES!
Lieve Tineke, 
Al 20 jaar zijn we samen en jij hebt me gemaakt wie ik nu ben. We hebben samen 
de wereld afgereisd, veel gezien, veel beleefd en we hebben drie prachtige 
meisjes gekregen. We hebben samen een hele moeilijke tijd gehad het afgelopen 
jaar. Nu ik dit schrijf hangen er donkere wolken boven ons, maar ik heb het 
gevoel dat de zon elk moment kan doorbreken. Ik hoop dat de toekomst nog veel 
wolkeloze luchten voor ons in petto heeft. In elk geval heb je me laten zien wat 
echte onvoorwaardelijke liefde is in de letterlijke zin van het woord. Jij houdt me 
overeind. Hiervoor ben ik je oneindig dankbaar!
Marit, Hester en Aniek,
Als ik thuis kom word ik steevast begroet door allemaal kleine meisjeshandjes die 
van alles voor me geknutseld en getekend hebben. Jullie zijn alle drie onderweg 
fantastische mensen te worden waar ik ontzettend trots op ben, elke dag weer. Ik 
geniet ervan jullie pappa te mogen zijn! 
Lieve Marit, wat ben jij een ontzettend grote meid aan het worden! Ik geniet 
ervan te zien hoe jij de laatste tijd de wereld om je heen aan het ontdekken bent 
en hoe je met allemaal vragen bij me komt. Ik ben er zo trots op hoe jij een slimme 
en lieve meid aan het worden bent! Jij hebt een speciaal plekje in mijn hart!
Lieve Hester, jij bent mijn heerlijke spring-in-het-veld en dondersteen. Wat 
kan ik genieten van jou! Jij stelt me elke dag weer voor nieuwe uitdagingen en 
verassingen. Ik voel me bevoorrecht te zien hoe jij lekker eigenwijs je eigen ding 
doet zonder je wat van anderen aan te trekken! Ik hoop dat je altijd zo zult blijven! 
Ik ben zo trots op jou!
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Lieve Aniek, zoals opa al zei ben jij een echt cadeautje! Altijd goede zin en lachen. 
Het leven is een feest voor jou en met jou! Bij jou in de buurt wordt iedereen 
vrolijk! Zo klein als je bent ben je de wereld al aan het verkennen en ontdekken. 
Je grote zussen helpen je bij alles en daar weet jij op een heerlijke manier gebruik 
van te maken, want je krijgt alles voor elkaar bij ze. Jij maakt ons gezin en mij 
compleet!
Lieve meisjes, jullie relativeren mijn hele leven. Ik hou zielsveel van jullie! Zonder 
het te weten zijn jullie degenen die mijn leven waard maken geleefd te worden!
       Frank
